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Abstract 
Background: Epidemiological evidence supports a strong association between 
exposure to inhaled toxins and adverse respiratory outcomes such as 
pneumococcal pneumonia and chronic respiratory conditions such as chronic 
obstructive pulmonary disorder (COPD). Chronic exposure to airborne particulate 
matter in occupational settings, such as welding, has been shown to reversibly 
increase risk of pneumococcal pneumonia. However, biological plausibility of this 
has not been shown and the molecular mechanisms are unknown. Chronic cigarette 
smoking causes reduced lung function and increased morbidity in COPD patients. 
These patients are highly vulnerable to viral and secondary pneumococcal 
infections. The molecular mechanisms are unclear.  
Methods: Association between exposure to welding fumes (WF) and susceptibility to 
pneumococcal infection, rhinoviral infection and rhinoviral+secondary 
pneumococcal infection was assessed in lower airway and nasal epithelial cells in 
vitro. The role of the platelet activating factor receptor (PAFR), which is an entry 
receptor for the pneumococcus, was also assessed. Using two methods of WF 
exposure, susceptibility to pneumococcal infection following acute and chronic 
exposure was assessed in mice. Finally, PAFR expression was examined in the 
lungs of non-smokers, welders, smokers and smokers with COPD.  
Results: Exposure of alveolar, bronchial and nasal epithelial cells to WF significantly 
increases pneumococcal invasion of these cells in a PAFR dependent manner. 
Exposure to WF increases susceptibility to infection by rhinovirus and vulnerability 
to secondary pneumococcal infections in a PAFR dependent manner. Exposure to 
WF increases susceptibility of mice to pneumococcal infection and PAFR mRNA 
expression levels in the lungs. Finally, PAFR mRNA levels are elevated in smokers 
with COPD compared with non-smokers. PAFR protein expression in the lungs of 
smokers with COPD is localised to the bronchial epithelium and bronchial glands. 
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Conclusions: PAFR is a potential anti-infective agent in pneumococcal pneumonia 
caused by exposure to WF and in COPD caused by chronic exposure to smoking. 
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1.1 Environmental and occupational exposure to airborne particulate matter 
and respiratory infections  
Pneumonia was first described as a disease by Hippocrates in the 4th century BC. 
However, it wasn’t until the 19th century that Edward Klebs observed bacteria in the 
airways of people who had died from pneumonia and Carl Friedlander and Albert 
Frankel identified Streptococcus pneumoniae (S. pneumoniae) as a bacterial cause 
of the disease.  
Pneumonia is the cause of death in 1 in 5 children in the developing world and is a 
major cause of morbidity in the developed world. S. pneumoniae is the most 
common causative agent of pneumonia1–3. Although it causes invasive disease, the 
Gram positive bacterium is carried by a large proportion of the population without 
any symptoms of disease.  
Viral pneumonia is caused by viruses such as respiratory syncytial virus (RSV) and 
rhinoviruses (RVs). Viral pneumonia is difficult to diagnose and is not commonly 
associated with fatalities. However, viral infections may predispose susceptible 
individuals to secondary bacterial infections which may further exacerbate the 
pneumonia, causing increased risk of death. 
Welding, which has previously been a target occupation for the Disease Reduction 
Programme in the UK, has been associated with pneumonia, occupational asthma 
and cancer4,5. Currently, several million people worldwide are full time occupational 
welders. 
In this thesis the focus is on the effect of inhaled toxin exposure on interactions 
between the host and S. pneumoniae and human rhinoviruses, and on 
rhinoviral/pneumococcal interactions during co-infection of the host, in the context of 
bacterial pneumonia. In this chapter, the literature around S. pneumoniae and 
rhinovirus infection and viral-bacterial co-infections will first be reviewed. Then, the 
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evidence of interactions between sources of air pollution and infection will be 
reviewed. 
1.1.1 Streptococcus pneumoniae: importance of adherence  
Adherence of pneumococci to airway epithelial cells is the first step of 
pathogenesis6,7. Proteins found on the surface of the pneumococcus called 
adhesins mediate this adherence. One such adhesin is phosphorylcholine (ChoP) 
which has strong structural similarities to the human platelet activating factor (PAF) 
and is recognised by and binds the PAF receptor (PAFR). PAFR is a G coupled 
receptor which is rapidly internalised after it binds its ligand8. This endocytosis has 
been shown to be mediated by β arrestin 1 which targets PAFR to clathrin coated 
pits9. Hence, S. pneumoniae co-opts PAFR for entry into human cells. It has been 
shown that in respiratory epithelial cells infection with S. pneumoniae induces 
expression of the transcription factor, CCAAT enhancer binding protein δ (C/EBPδ), 
which in turn induces the expression of PAFR, as shown in figure 110. PAFR mRNA 
and protein expression was observed in nasal epithelial cells purified from the nasal 
mucosa of human subjects. Expression was also observed in submusocal glands11. 
Other adhesins present on the pneumococcal surface, such as lipoprotein 
pneumococcal surface adhesin (PspA), have also been shown to be involved in 
mediating the attachment of bacteria to both nasopharyngeal and lower airway 
epithelial cells12.  
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Figure 1: S. pneumoniae co-opts PAFR for entry into human epithelial cells. S. 
pneumoniae induces expression of C/EBPδ in airway epithelial cells which in turn 
upregulates PAFR expression. Pneumococci then bind PAFR and invade cells via 
clathrin coated pits.  
 
There are a few studies about methods of blocking pneumococcal adherence to 
airway epithelial cells. One such study found that the probiotic, lactobacillus 
rhamnosus GG (LGG), binds to epithelial cells and prevents pneumococcal 
adherence. This probiotic had no effect on the release of inflammatory cytokines by 
the cells13. The antibiotic, erythromycin, has also been shown to decrease 
erythromycin-resistant pneumococcal adherence to airway epithelial cells and delay 
the disruption of the epithelial layer. Release of interleukin 8 (IL-8) by the cells was 
not, however, attenuated by the antibiotic14. S-carboxymethylcysteine (S-CMC), a 
mucolytic drug, has also been shown to reduce adherence of S. pneumoniae to 
airway epithelial cells. PAFR mRNA and protein expression were also inhibited by 
this drug15.  
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The airway epithelium is the first line of defence against pneumococcal invasion. 
Alveolar epithelial cells produce, secrete and recycle the alveolar lining fluid which 
contains cytokines such as TNF-α and IL-6, defensins, surfactant proteins and 
components of the complement system which are all involved in the innate immune 
response to microbial infections16. It has also been shown that tracheal submucosal 
glands secrete lysozyme which is an antimicrobial17. A study of airway epithelial 
cells also showed that infection with pneumococci causes the release of 
antimicrobial peptides, such as defensins, and the activation of nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB), which is a pro-inflammatory 
transcription factor18. Epithelial cells activate the innate immune response which 
leads to the recruitment of macrophages to the site of infection. Mice in which the 
receptor for the immunomodulatory lipid, prostaglandin E2, was knocked out 
showed increased bacterial clearance and survival and increased neutrophilia in the 
lungs. Alveolar macrophages from these mice also showed increased phagocytosis 
of S. pneumoniae and increased tumour necrosis factor α (TNF-α) release19. 
Studies of alveolar macrophages also showed that pneumococcal uptake followed 
by intracellular digestion of pneumococcal peptidoglycan and pneumolysin-
dependent sensing by the pattern recognition receptor, nucleotide-binding 
oligomerisation domain-containing protein 2 (Nod2), leads to the release of 
chemokines for the recruitment of more macrophages to the site of infection20. It 
was observed that the release of inflammatory molecules, such as interferons, and 
the activation of the cytosolic microbial DNA sensing mechanisms was also 
dependent on the presence of pneumolysin in the cytosol, after pneumococcal 
phagocytosis by alveolar macrophages21. Complement activation provides both 
antibody dependent and independent protection against pneumococcal infection. 
The complement system may be activated by the classical, alternative or the lectin 
pathways22,23. It has been shown that complement proteins, such as C1q, may be 
able to bind directly to the pneumococcus in an antibody independent manner. 
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These interactions have been shown to be mediated by bacterial surface proteins 
and to facilitate pneumococcal adherence and invasion of airway epithelial cells24. 
Mouse knockout studies have also implicated other molecules such as the receptor 
for IL-1 and the scavenger receptor, CD36, in immunity against pneumococcal 
infection. Mice deficient in the IL-1 receptor had higher mortality rates and bacterial 
burdens although neutrophil recruitment was not affected. In these mice activation 
of fibrinogen genes involved in coagulation, which is believed to confer protection 
against invasive pneumococcal disease, was not observed25. CD36 negative mice 
showed increased inflammation but decreased bacterial clearance and 
phagocytosis of pneumococci by alveolar macrophages. CD36 has been shown to 
be expressed by alveolar macrophages and respiratory epithelial cells26. 
Pneumococcal persistence in the respiratory epithelium and activation of the 
immune response leads to disruption of the epithelial barrier and tissue damage. 
This allows the pneumococci to translocate across the epithelial barrier into the 
blood stream and cause invasive disease. It has been shown that the PAFR-
pneumococcus complex is endocytosed in a clathrin-dependent manner. β arrestin 
1 is involved in targeting this endocytosed vacuole away from the lysosome and 
back to the cell surface9. This is a suggested mechanism for pneumococcal 
transcytosis across the epithelial barrier. Hypoxia inducible factor has also been 
implicated in pneumococcal transcytosis due to its role in inducing and regulating 
PAFR expression by binding to the promoter region of the PAFR gene27. 
1.1.2 Rhinovirus infection 
Virus associated pneumonia is common in both adults and children, with 
rhinoviruses being one of the leading causative agents, alongside influenza and 
respiratory syncytial virus28,29. Secondary infections by bacteria such as S. 
pneumoniae exacerbate respiratory symptoms and pneumonia30. The role of 
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rhinoviruses in infection will be reviewed first followed by a review of the interactions 
between viruses and bacteria when they co-infect a host. 
Rhinoviruses (RVs) are positive single stranded RNA viruses of the picornavirus 
family. They cause the common cold and have been implicated in exacerbations of 
asthma and COPD31. Intracellular adhesion molecule 1 (ICAM-1), which is an 
integral membrane protein, has been shown to be an entry receptor for RVs in 
human cells32. In respiratory epithelial cells it has been shown that RV infection 
upregulates the expression of ICAM-1 in an NF-κB-dependent manner. NF-κB binds 
to the promoter region of the ICAM-1 gene and induces its expression after RV 
infection, as shown in figure 233. Higher protein and mRNA expression levels of 
ICAM-1 and NF-κB have been observed in the nasal mucosa of human subjects 
with rhinitis34. It has also been shown that virus replication, viral load, the 
intracellular anti-viral response and the release of cytokines such as IL-8 and IL-1α 
are higher in human bronchial epithelial cells compared to human nasal epithelial 
cells35.  
 
Figure 2: Rhinoviruses infect human cells via ICAM-1. RVs induce NF-κB 
expression, which in turn upregulates ICAM-1 expression. ICAM-1 is a known entry 
receptor for RVs in human cells. RV infection of airway epithelial cells has been 
shown to cause release of pro-inflammatory cytokines such as IL-8 and IL-1α. 
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A few studies have shown that antibiotics and mucolytic drugs may be used to treat 
rhinovirus infections. A study in bronchial epithelial cells showed that treatment with 
the macrolide, azithromycin, upregulates the antiviral interferon response and other 
antiviral genes. Viral replication and release was inhibited by the drug36. Another 
study showed that levofloxacin reduces viral load, cytokine release, ICAM-1 
expression and NF-κB activation in human tracheal cells. A similar study showed 
similar effects of the mucolytic drug, carbocisteine, in tracheal cells37,38. Iota 
carrageenan, a sulphated galactose polymer derived from Rhodophycae seaweed 
has been shown to inhibit RV growth, replication and entry into nasal epithelial cells 
in vitro. The compound has been approved for use as a nasal spray after studies in 
both adults and children showed that it reduces viral replication and the release of 
pro-inflammatory cytokines such as IL-839–41.  
1.1.3 Viral and secondary bacterial co-infections 
Secondary bacterial infections are a common occurrence following viral infection. 
They may exacerbate chronic respiratory conditions, such as asthma and COPD, 
which may lead to fatalities due to pneumonia28,29. 
In a study of pharyngeal cells co-infected with respiratory syncytial virus (RSV) and 
pneumococci, it was found that adherent pneumococci had increased transcriptional 
levels of genes encoding adhesins such as PspA and genes involved in choline 
uptake and incorporation42. These data have implications for bacterial adherence to 
respiratory epithelial cells, as alluded to earlier. An in vitro study using human 
pharyngeal cells showed that exposure to polyinosinic:polycytidylic acid (poly I:C), 
which is  structurally similar to double stranded RNA contained in many viruses and 
hence stimulates the anti-viral response, increased PAFR mRNA and protein 
expression. Pneumococcal adherence to these cells was also increased and was 
attenuated using a PAFR antagonist. In this study it was also observed that the 
PAFR antagonist did not affect basal levels of adherence of S. pneumoniae to the 
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cells43. In a study in mice it was observed that treatment with poly I: C followed by 
pneumococcal infection reduced bacterial clearance and increased mortality. These 
effects were dependent on the activation of antiviral mechanisms such as retinoic 
acid-inducible gene 1 (RIG-1) signalling, which is involved in the recognition of viral 
nucleic acid, and interferon production. In mice deficient in type I interferon 
signalling the impairment of bacterial clearance was not observed44. In an in vitro 
study of lower airway epithelial cells it was observed that infection with viruses such 
as influenza and RSV promoted adherence of H. influenzae and S. pneumoniae. 
Differential regulation of human adhesion molecules such as PAFR was seen by the 
different viruses used in the different cell types tested. Basal levels of these 
molecules also differed by cell type45. A few mouse studies have shown a 
synergistic effect of influenza infection followed by pneumococcal infection on 
weight loss, survival, airway repair responses and apoptosis of airway epithelial 
cells and alveolar macrophages46,47. Additionally, in influenza infected PAFR 
deficient mice or mice treated with a PAFR antagonist reduced lethality, lung injury 
and neutrophil recruitment was observed. PAFR expression was higher in mice co-
infected with influenza and S. pneumoniae compared to mice infected with either 
influenza or S. pneumoniae alone48,49. In mice and in vitro it has also been shown 
than co-infection of rhinovirus and H. influenzae causes reduced chemokine 
production by lung epithelial cells and reduced neutrophil recruitment to the lungs50. 
An in vitro study also showed increased pneumococcal adherence to rhinovirus 
infected epithelial cells. An increase in PAFR expression and NF-κB activation was 
also observed. The increased adherence of pneumococci was attenuated by both a 
PAFR blocker and an antibody against ICAM-1, which is an entry receptor for 
rhinoviruses30. RSV infection increased PAFR expression in lower airway epithelial 
cells. Treatment of cells infected with the virus with fosfomycin, an antimicrobial and 
immunomodulatory agent, attenuated this increased PAFR expression and 
pneumococcal adherence to the cells51. 
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In the following sections the different types of air pollution and their effects on the 
respiratory system and respiratory infections will be reviewed, with a focus on 
pneumococcal pneumonia. 
1.1.4 Types of airborne environmental pollutants 
Both indoor and outdoor air pollution are major health risks in both the developing 
and developed world. Sources of pollution may broadly be divided into fuel 
combustion, tobacco smoking and occupational.  Pollutants may be particulate or 
gaseous in nature. Further, exposures may be in outdoor or indoor settings. In the 
following sections, the evidence that exposure to the different types of air pollution 
increases vulnerability to respiratory disease and pneumococcal infection will be 
reviewed.  
1.1.5 Indoor and outdoor air pollution caused by fuel combustion 
Air pollution caused by fuel combustion may be from a variety of sources. Typical 
sources of indoor air pollution include the combustion of biomass or wood. Outdoor 
air pollution may be in the form of diesel exhaust particles, carbon black, 
nanoparticles or miscellaneous metallic particulate matter with an aerodynamic 
diameter < 10µm (PM10). 
1.1.6 Air pollution and respiratory disease: epidemiology 
Globally, billions of people rely on biomass such as wood charcoal and dung for 
fuel. Biomass smoke contains a number of pollutants such as particulate matter, 
carbon monoxide and sulphur oxides. Exposure to indoor air pollution has been 
implicated in respiratory illnesses such as acute respiratory infections and chronic 
obstructive pulmonary disease (COPD) and maternal exposure is a risk factor for 
low birth weight. The National Ambient Air Quality Standards of the U.S. 
Environmental Protection Agency recommends a 24 hour average exposure to PM10 
of 150µg/m3,  which is not to be exceeded more than once a year over a 3 year 
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period, whereas exposures may be in the range of 200-5,000µg/m3 in a household 
using biomass as a primary source of energy52. The European Directive limit of 
exposure, which the UK must comply with, is a mean of 50µg/m3 over a 24 hour 
period which is not to be exceeded more than 35 times a year53. According to 
estimates for the period 2000-2003, presented by the WHO, 19% of deaths in 
children aged < 5 years were due to acute respiratory infections, for which  
exposure to indoor air pollution is a major risk factor54. Recent WHO estimates show 
that 4.3 million people a year die from exposure to indoor air pollution (accessed 
13th January 2015). In a study conducted in Pakistan it was shown that exposure to 
biomass smoke is associated with chronic bronchitis in women. However, as the 
smoking status of the women in the study was unknown smoking was a 
confounder55. Additionally, in a study of 271 female children under the age of 5 
years in Gambia it was found that carriage of the child on the mother’s back during 
cooking increased the risk of lower respiratory tract infections56. A study of 244 
children aged 1-3 years in Zimbabwe revealed an association between indoor 
exposure to wood smoke and risk of infection57. Higher exposure to domestic smoke 
was associated with moderate to severe acute respiratory illness in children less 
than 2 years of age in Nepal58.  
COPD, which is a growing global epidemic, is exacerbated by viral and bacterial 
infections. Rhinoviruses, H. influenzae and S. pneumoniae are frequently 
associated with COPD exacerbations59,60. The disease was previously considered a 
disease of the developed world caused by chronic cigarette smoking. However, 
epidemiological evidence shows an association between exposure to smoke 
produced by the burning of biomass fuels and the risk of developing COPD. A 
systemic review conducted in 2009 showed an association after adjusting for 
confounding factors such as cigarette smoking61. A study conducted in Spain also 
showed independent associations of wood and charcoal smoke exposures with 
 33 
 
COPD. This study was also adjusted for confounding factors such as smoking. 
Similar studies have also been conducted in Mexico and in areas of low socio-
economic status in Colombia62,63. In a study conducted in California between 2000 
and 2003 an association between acute exposure to particulate matter (PM), from 
the combustion of fuels such as gasoline and diesel, and hospitalisation for 
respiratory illnesses such as pneumonia and bronchitis has been shown in children 
< 5 years of age and < 19 years of age64. Additionally, in a European study of 10 
birth cohorts a significant association between parent reports of physician 
diagnosed pneumonia and air pollution was found in children aged 12-36 months65. 
1.1.7 Air pollution and respiratory disease: mechanisms 
In vitro studies have shown that lower airway epithelial cells such as alveolar cells 
take up particulate matter into vesicles in the cytoplasm66. Genetic profiling of 
bronchial epithelial cells, in vitro, showed an upregulation of genes involved in the 
oxidative stress response after exposure to PM67. Further, when these cells were 
exposed to PM there was an increase in intracellular reactive oxygen species (ROS) 
which in turn lead to an increase in transforming growth factor β1 (TGF-β1) and 
fibronectin produced by the cells. Both these molecules play key roles in wound 
repair mechanisms which are aberrant in pulmonary fibrosis. In this system the use 
of an anti-oxidant, N-acetyl cysteine (NAC), attenuated ROS production and thus 
the production of TGF-β1 and fibronectin by these cells68. NAC replenishes stores of 
the biologic anti-oxidant, glutathione. In a study of primary bronchial epithelial cells 
exposure to PM induced phosphorylation of protein kinases, such as extracellular 
signal-regulated kinase (ERK), which regulate the inflammatory response. Further, a 
glutathione transferase gene which is involved in the oxidative stress response, was 
knocked down in vitro, which significantly increased the production of PM stimulated 
inflammatory cytokines IL-8 and IL-1β. The use of NAC in this system inhibited the 
abovementioned phosphorylation of the protein kinases and subsequently the 
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production of IL-8 and IL-1β69. A study in alveolar epithelial cells confirmed the role 
of these protein kinases in the anti-oxidative stress response and showed that 
exposure to PM induces the nuclear factor erythroid-2-related factor 2 (Nrf2) 
signalling pathway which regulates intracellular defence mechanisms against 
oxidative stress70.  Exposure to PM has also been shown to inhibit cell proliferation 
and to induce the production of the pro-inflammatory cytokine, granulocyte 
macrophage-colony stimulating factor (GM-CSF), in bronchial epithelial cells71. 
Other in vitro studies have also shown an increase in the production of enzymes 
such as matrix metalloproteinase 1 (MMP-1) by bronchial epithelial cells and an 
increase in apoptotic tendency regulated by B-cell lymphoma 2 (Bcl2) and c-Myc, 
after exposure to PM72,73. MMP-1 is involved in the degradation of the airway extra 
cellular matrix and has been implicated in chronic respiratory diseases such as 
COPD and asthma.   
The activation of the inflammatory response by airway epithelial cells following PM 
endocytosis leads to the recruitment of inflammatory cells such as monocytes, 
macrophages and dendritic cells to the sites of deposition, which then perpetuate 
the immune response. There are a few studies which have looked at the PM-
mediated interactions between lower airway epithelial cells and monocytes or 
macrophages. These in vitro studies have shown that exposure to PM increases the 
production of inflammatory cytokines such as IL-8 and TNF-α in these systems14–17. 
Additionally, it has been shown that exposure to wood smoke particles significantly 
increased the production of inflammatory cytokines such as interleukin-6 (IL-6), IL-8 
and tumour necrosis factor α (TNF-α) in an airway epithelial cell/monocyte co-
culture system. Lactate dehydrogenase (LDH) release from damaged cells was also 
significantly increased.  Epithelial cells and resident macrophages in the alveoli are 
the primary cellular targets for particle deposition in the lungs and monocytes, which 
are the precursors of macrophages, accumulate in the alveoli during inflammation 
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and assist with particle clearance. Particle deposition in the alveolar region is highly 
uneven and clearance is slow. DNA damage, such as strand breaks, was also 
observed in both types of cells in vitro77,78. Further, it has been observed that 
exposure of monocytes/macrophages to PM stimulates calcium signalling mediated 
TNF-α release and inhibits the phagocytic function of these cells79,80. Phagocytosis 
is an important defence mechanism against bacterial infection. PM exposure 
enhances dendritic cell maturation, in vitro, which is a critical process in activating 
and mediating the T helper cell response which is part of the adaptive immune 
system81. Additionally, a study in mice showed that acute exposure to PM causes 
local and systemic inflammation and skews the T helper cell response82. Exposure 
of mice to PM caused an increase in vascular endothelial growth factor (VEGF) 
levels in the lungs which in turn led to protein leakage into the lungs and neutrophil 
infiltration, both of which cause lung inflammation and injury83. VEGF is a vascular 
permeability factor. Another in vivo study showed increased airway neutrophilia in 
PM exposed mice84.  
1.1.8 Air pollution and infection: mechanisms 
There are a number of studies which show an association between exposure to PM 
and incidence or severity of respiratory infections. In vitro studies in nasal epithelial 
cells showed increased replication of the virus which causes the common cold, RV, 
after exposure to PM. The release of inflammatory cytokines such as interferon γ 
(IFN-γ), IL-1β and IL-6 was also increased in these cells85. Another study in lower 
airway epithelial cells showed increased invasion of these cells by Streptococcus 
pneumoniae (S. pneumoniae) after exposure of the cells to PM. This increased 
invasion was attenuated by treatment of the cells with the anti-oxidant, NAC, and by 
treatment with a PAFR blocker. PAFR is co-opted by pneumococci for invasion of 
human cells86. PM exposed mice had a greater load of pneumococci in the lungs 
with alveolar macrophages displaying reduced lymphocyte activation activity87. 
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Another study showed that PM is a source of bioavailable iron for bacteria and that 
bacterial growth increased in the presence of PM. The study also showed that 
airway epithelial cells exposed to PM had decreased antimicrobial activity and that 
mice exposed to PM and infected with Pseudomonas aeruginosa (P. aeruginosa) 
showed decreased bacterial clearance88. Mice exposed to PM during an influenza 
infection had increased viral titres, increased numbers of neutrophils and increased 
levels of inflammatory cytokines in the lungs89. 
1.1.9 Tobacco smoking and respiratory disease: epidemiology 
Tobacco smoking is a leading cause of preventable deaths. Tobacco smoking and 
exposure to second hand smoke increase risk of adverse health outcomes such as 
heart disease, cancer and respiratory illnesses such as COPD in adults and 
pneumonia and bronchitis in both adults and children90. Smoking also affects the 
immune system and fertility91. COPD is a chronic respiratory disease, the main 
cause of which is chronic smoking, characterised by inflammation of the bronchi, 
damage to the small airways and alveolar sacs and restricted airflow. The disease is 
exacerbated by bacterial and viral infections which may also be fatal. According to 
the WHO approximately 3 million people die every year as a consequence of having 
COPD92,93. 
There is an association between cigarette smoking or passive exposure to cigarette 
smoke and respiratory infections. In Vietnam it was shown that over a 12 month 
period the number of hospital admissions of children < 5 years of age who were 
exposed to cigarette smoke was significantly higher than those unexposed94. 
Additionally, in a study of 500 children under the age of 5 years in Gambia an 
association between father’s smoking and risk of developing lower respiratory tract 
infections was found56. In a review of reports published between 1966 and 1995 it 
was found that children with a smoking parent were at twice the risk of developing a 
severe respiratory tract illness requiring hospitalisation, in early life95.  
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In adults, studies in India have shown a dose response relationship between 
tobacco smoking and pulmonary tuberculosis in 85 men aged 20-50 years and an 
association between risk of tuberculosis and smoking in 93945 individuals aged 
over 15 years96,97. Another study in India showed a relationship between smoking 
and under lying conditions such as COPD and community acquired pneumonia in 
70 patients98. In a study of non-elderly immunocompetent adults aged 18 to 64 
years in the US, smoking was found to be a strong independent risk factor for 
pneumococcal disease.  Increased risk was also associated with passive smoking99.  
1.1.10 Tobacco smoking and respiratory disease: mechanisms 
In vitro studies in nasal epithelial cells have shown that exposure to cigarette smoke 
extract (CSE) alters the immune response of these cells, with short term exposure 
suppressing the immune response and long term exposure triggering a pro-
inflammatory response100. Exposure of lower airway epithelial cells, such as alveolar 
and bronchial epithelial cells, to tobacco smoke or cigarette smoke condensate 
(CSC) showed an increase in the release of inflammatory cytokines such as IL-6, IL-
8 and IL-1β in a mitogen activated protein (MAP) kinase and  nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-κB) dependent manner101,102. MAP 
kinases are part of the signalling pathway which leads to the activation of NF-κB 
which is a ubiquitous pro-inflammatory transcription factor.  
Cigarette smoke exposure of murine lower airway epithelial cells from Nrf2 deficient 
mice caused greater injury compared to cells from wild type mice. This effect was 
reversed by the use of the anti-oxidant NAC103.  As mentioned earlier, Nrf2 is 
involved in oxidative stress defence mechanisms and NAC acts by restoring 
glutathione, which is a biological anti-oxidant, levels. Another anti-oxidant, vitamin 
C, was used in alveolar epithelial cells and in guinea pigs to show a reduction in NF-
κB activation after exposure to cigarette smoke104. An in vitro study of alveolar 
epithelial cells showed an increase in aldehyde and oxidant induced apoptosis after 
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exposure to CSE105. Further, exposure of alveolar epithelial cells and mice to 
cigarette smoke induced cellular senescence in the lung epithelium106. It also 
induced endoplasmic reticulum (ER) stress caused by reduced activity of the 
ubiquitin-proteosome pathway which leads to the accumulation of damaged 
proteins107,108. Cellular senescence and ER stress cause epithelial cell death, 
disruption of the epithelial barrier and prevention of proliferation for repair, which all 
contribute to the development of chronic lung diseases such as COPD.  Expression 
of MER tyrosine kinase (MERTK), a transmembrane tyrosine kinase receptor 
involved in the phagocytosis of apoptotic cells, in alveolar macrophages was also 
observed to be significantly higher in smokers compared to non-smokers109. This 
may reflect the increased apoptosis of lower airway epithelial cells observed in vitro. 
Additionally, an increase in oxidative stress, DNA fragmentation and apoptosis was 
observed in lung fibroblasts, which are involved in airway remodelling, after 
exposure to CSE in vitro110. In vitro chemotaxis assays demonstrated that exposure 
of alveolar epithelial cells to CSE stimulated chemotactic activity in monocytes and 
neutrophils111. This suggests that exposure to CSE modulates the recruitment of 
inflammatory cells to the lungs. Indeed, repeated exposure of guinea pigs to 
cigarette smoke for 14 days caused significant neutrophilia in the lungs112. In 
addition, exposure to CSE increases the release of platelet activating factor (PAF) 
by endothelial cells. PAFR promotes trans-endothelial migration of inflammatory 
cells into the airways. In this study a PAFR receptor (PAFR) blocker, CV-3988 
which mimics PAF, attenuated the adherence of leucocytes to the endothelial 
cells91. 
1.1.11 Chronic smoking and COPD: mechanisms 
Bronchial epithelial cells from COPD patients have been shown to constitutively 
release higher levels of IL-6 and IL-8. Stimulation of these cells with 
lipopolysaccharide (LPS), which is a bacterial endotoxin, from P. aeruginosa has 
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been shown to attenuate inflammatory responses such as IL-8 release and NF-κB 
activation113. These findings suggest that the immune response to bacterial 
infections is suppressed in COPD patients, which is in line with observations of 
increased susceptibility to infections in these patients. The bronchial epithelium from 
these patients has also been shown to express lower levels of the anti-oxidant 
gene, catalase, compared to non-smokers and smokers without COPD. Catalase 
blocks the activation of NF-κB and decreased levels in mice has been shown to 
cause increased cell death114. Smoking has also been shown to reduce the 
phagocytic function of alveolar macrophages, which is a key lung defence 
mechanism, in both smokers and COPD patients. It was also observed that the 
phagocytic function of these macrophages is better in COPD patients who are ex-
smokers compared to those who are current smokers115. Goblet cell metaplasia, 
which contributes to airway obstruction and causes mucus hypersecretion, has 
been shown to be higher in the trachea in a guinea pig model of COPD. Increased 
numbers of neutrophils were also seen in the broncho-alveolar lavage fluid (BALF). 
A PAFR antagonist attenuated both the increased goblet cell metaplasia and the 
increased neutophilia in this model116.  
Rhinovirus infections are a common cause of COPD exacerbations and secondary 
bacterial infections are commonly reported. In a human model of experimental 
rhinovirus infection it was found that a significantly higher proportion of COPD 
patients developed secondary bacterial infections compared to healthy smokers and 
non-smoking controls. The COPD patients that developed secondary bacterial 
infections had lower sputum levels of antimicrobial peptides which inversely 
corresponded with bacterial load. They also had higher viral loads60. 
1.1.12 Cigarette smoking and infection: mechanisms 
A study showed that lipopolysaccharide (LPS), which is a bacterial endotoxin and 
an inflammatory stimulus, is a component of cigarette smoke117. In a study of the 
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oral microflora of smokers it was found that the growth of P. aeruginosa is not 
inhibited by smoking but the growth of S. pneumoniae and Haemophilus influenzae 
(H. influenzae) is118. In vitro studies in buccal cells from smokers and non-smokers 
showed increased adhesion of bacteria such as S. pneumoniae and H. influenzae to 
cells from smokers119,120. This suggests that although the growth of some bacteria 
may be inhibited by exposure to cigarette smoke, exposure to the smoke makes 
airway epithelial cells more susceptible to invasion by these bacteria. Bacterial 
adherence to epithelial cells is the first step in the colonisation process. Other in 
vitro studies have shown that exposure of upper airway epithelial cells to CSE or 
CSC followed by infection by bacteria such as Staphylococcus aureus (S. aureus) 
and H. influenzae decreases production of inflammatory cytokines such as IL-8 and 
IL-6 and activation of the pro-inflammatory transcription factor NF-κB121,122. It has 
also been shown that exposure of lower airway epithelial cells to CSE, in vitro, 
increases vulnerability to pneumococcal infection. This vulnerability was attenuated 
by a PAFR blocker in this study. This study also showed that PAFR expression was 
increased in the lungs of mice exposed to cigarette smoke. Bronchial epithelial 
PAFR protein expression was also raised in smokers’ lungs123. 
In a study of current and former smokers with acute pneumonia it was observed that 
pharyngeal wash fluid and sputum had reduced levels of antibacterial peptides such 
as human β defensin 2 (hBD-2)124. This suggests that cigarette smoking supresses 
the pulmonary innate immune system. A mouse study showed that exposure to 
cigarette smoke and infection with Mycoplasma pneumoniae (M. pneumoniae) 
caused an increase in DNA oxidation in the lungs. This increase was also observed 
in lung epithelial cells in vitro125. Buccal cells of rats chronically exposed to cigarette 
smoke, in vivo, were more susceptible to pneumococcal adherence126. Additionally, 
mice chronically exposed to cigarette smoke and infected with S. pneumoniae had 
greater lung infiltration by macrophages and neutrophils and higher levels of 
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inflammatory molecules such as TNF-α in the lungs. They also displayed more 
weight loss. However, in this model, bacterial burden in mice exposed and 
unexposed to cigarette smoke was comparable127. In a more susceptible mouse 
pneumococcal model it was observed that bacterial burdens were higher in cigarette 
smoke exposed mice compared to the controls. In this study it was also shown that 
alveolar macrophages exposed to CSE in vitro and infected with S. pneumoniae 
had reduced phagocytic activity128.  
Cigarette smoking not only alters host defence systems, as outlined above, but also 
affects the pathogens that cause respiratory infections. Exposure of S. pneumoniae 
to CSC increased its ability to form biofilms and the pore forming activity of a major 
toxin, pneumolysin. Biofilm formation insulates pathogens from host defence 
systems, which prolongs bacterial persistence129. Other studies have also shown 
alterations in expression of virulence genes in bacteria such as Porphyromonas 
gingivalis (P. gingivalis) after exposure to cigarette smoke130.  
1.1.13 Occupational exposures to airborne particulate matter 
Workers across a number of industries worldwide are chronically exposed to 
hazardous agents such as biological and chemical agents, and radiation in 
occupational settings. The National Institute for Occupational Safety and Health, 
which is part of the Centre for Disease Control and Prevention (USA), has identified 
exposure to aerosols such as dust, diesel emissions, nanotechnology and metal 
fumes as a significant area of concern. Additionally, a recent systematic literature 
review revealed an association between occupational exposure to vapours, gas, 
dust and fumes and the risk of COPD, both within and across different industry 
groups131. 
The focus of this thesis is metal fumes and more specifically, welding fumes. 
Welding (figure 3) has previously been included as a target occupation for the 
 42 
 
Disease Reduction Programme (DRP) because of severe ill-health effects seen in 
welders. The DRP is part of the work done by the Health and Safety Executive 
which is the independent watchdog for occupational health and safety in the UK. 
 
Figure 3: Welding is a sculptural or fabrication process by which two metal work 
pieces are joined. An electric arc is often used as a source of energy for the 
process. The image was adapted from the National Careers Service website (UK) 
on 9th February 2014. 
1.1.14 Occupational exposure to metal fumes  
Epidemiology: Several million people worldwide are currently estimated to be full 
time occupational welders. Occupational exposure to welding fume is associated 
with adverse respiratory outcomes such as lobar pneumonia, asthma and lung 
cancer. A number of epidemiological studies conducted in countries such as the UK, 
US and Sweden have shown an association between welding and a decline in lung 
function. Some of these studies suggest a greater effect in welders who smoke. It is 
currently estimated that the total welding fume dose that welders are exposed to 
during their working lives is approximately 80mg/m3*years132,133. Welding is the 
fusion of metals at a high temperature generated using a gas metal arc (GMA). Mild 
steel (MS) wires are the most commonly used in welding but the use of stainless 
steel (SS) wires protects the weld from corrosion. Fume generated by welding is a 
mixture of compounds of metals such as iron, chromium and manganese. 
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Mechanisms: In an in vivo study in mice chronically exposed to welding fumes by 
aspiration, the lung transcriptome was analysed and it was observed that genes 
implicated in immunological disorders, cancer and cell death were dsyregulated134. 
In another study in cynomolgus monkeys, which have a highly homologous genome 
to humans, genetic profiling of the lungs revealed that chronic inhalation exposure 
to welding fume caused the dysregulation of genes involved in inflammation, cancer 
and the cell cycle. Histopathological analysis of the lungs showed deposition of 
welding fume in the airways135. This was similar to a rat study in which rats were 
chronically exposed to stainless steel welding fumes. Inflammatory cell influx and 
pulmonary injury were observed in these rats. Further, iron, chromium and nickel 
complexes were observed in the lungs and in alveolar macrophages136. A 
histopathological study in welders also showed weld generated particulate matter in 
the lungs137. In a mouse study it was observed that chronic exposure to welding 
fumes by aspiration caused a significant increase in lung tumour multiplicity138. 
Additionally, in rats a higher number of macrophages and neutrophils and an 
increased amount of TNF-α was observed in the bronchoalveolar fluid (BALF)139. In 
another in vivo study DNA damage in the lung was seen in rats chronically exposed 
to welding fumes by inhalation140. A study in alveolar epithelial cells showed an 
increase in IL-8 production and the production of ROS in these cells after exposure 
to welding fume in vitro. A depletion of cellular glutathione levels was also observed 
in this system141.   
1.1.15 Welding and pneumonia 
Epidemiology: In a study of occupational mortality in England and Wales in welders 
aged 15-64 years it was found that mortality from pneumonia was higher in 1959-
1963 and in 1970-1970. Additionally, mortality from pneumococcal and lobar 
pneumonia was increased in 1979-1980 and in 1982-1990.  No excess in deaths 
was seen in men aged above the retirement age (65 years)142. In a case control 
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study conducted in 1996-1999 in men aged 20-64 years it was observed that 
pneumonia was associated with exposure to welding fume within a year of 
hospitalisation in 525 welders compared to 1,122 controls4. Finally, in a study of 
deaths due to pneumonia in 1991-2000 in men aged 16-74 years it was found that 
observed deaths, due to lobar pneumonia, were significantly higher than expected 
deaths. However, this was not the case in men of older ages143. Taken together, the 
data suggest that exposure to welding fume reversibly increases susceptibility to 
pneumonia. A retrospective chart review of invasive pneumococcal disease in 2000-
2004 in men aged 18-65 years in Canada showed a 2.7 fold greater incidence of 
disease in welders compared to the general population. 15 of the 18 welders in the 
study were current or former smokers, making the rate of smoking in welders higher 
when compared the general population. This suggests that cigarette smoking is 
highly prevalent amongst welders and hence exposure to cigarette smoke is an 
additional risk factor for these individuals144. 
Mechanisms: Very little is known about the mechanisms that cause this increased 
susceptibility of welders to pneumonia. In rats exposed to welding fume and infected 
with Listeria monocytogenes (L. monocytogenes) a higher bacterial burden was 
observed145,146. 
1.1.16 Exposure to inhalable particulate matter and viral/bacterial interactions 
during co-infection: mechanisms 
There is very little known about how exposure to pollutants may affect viral/bacterial 
interactions in diseases such as pneumonia. A study in rat lung epithelial cells 
showed that exposure to diesel exhaust particles increased mRNA expression of 
ICAM-1, PAFR and a marker of oxidative stress, heme oxidase-1147. These data 
suggest that exposure to PM may increase susceptibility to airway epithelial cells to 
viral and bacterial infections. Exposure of RV infected bronchial epithelial cells to 
CSE caused a suppression of antiviral response genes such as melanoma 
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differentiation-associated protein 5 (MDA5) and RIG-1 in those cells. Both 
molecules are cytoplasmic RNA helicases which sense double stranded RNA. 
Interferon production, which is also part of the antiviral response, was not inhibited 
by CSE exposure in these cells148. 
1.2 Summary 
Pneumonia is one of the leading causes of deaths worldwide. The major causative 
agent of bacterial pneumonia is S. pneumoniae. Exposure to airborne particulate 
matter, such as in occupational settings and cigarette smoking, is a major risk factor 
for respiratory diseases such as pneumonia and COPD. Infection with viruses such 
as rhinoviruses increases susceptibility to secondary bacterial infections and 
exacerbates pneumonia and COPD.  
As evidenced by a review of the literature above, very little is known about the 
molecular mechanisms involved in causing susceptibility to pneumococcal infections 
in welders. Currently in the UK welders are not routinely offered the pneumococcal 
vaccine. Identifying the mechanisms involved is the first step towards developing 
therapies for targeting pneumococcal pneumonia in welders. 
 
1.3 Aims 
The aims of this thesis are to: 
 Determine the effect of welding fumes on pneumococcal and rhinoviral and 
secondary pneumococcal infections in the lower airway epithelium. 
 Establish whether PAFR expression is elevated in the bronchial and alveolar 
epithelium of smokers with COPD. 
 
 
 46 
 
1.4 Hypotheses 
1. Exposure to metal fumes generated during welding increases vulnerability 
to: 
o Pneumococcal infections in a PAFR and oxidative stress dependant 
manner. 
o Rhinoviral infections and secondary pneumococcal infections. 
2. COPD patients, who are highly susceptible to both viral and bacterial 
infections, have increased PAFR expression in the lung epithelium. 
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Chapter 2: Methods 
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2.1 Cell culture 
A549s are type II pneumocytes isolated from a carcinoma. For this study the cells 
were obtained from Sigma Aldrich (UK). Cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) and 1% L-glutamine 
(G)/penicillin-streptomycin (P/S) (Lonza, Switzerland). Passage number was <20. 
Experiments were conducted using incomplete DMEM without either FBS, G or P/S.  
BEAS-2B cells are bronchial epithelial cells that were isolated from a healthy 
individual and transformed using Simian virus 40. For this study the cells were 
kindly donated by Dr Nicolas Mercardo (National Heart and Lung Institute, Imperial 
College London, UK). The cells were initially grown in DMEM as above but it was 
found that during experiments in incomplete media the cells lifted off the plates. 
Thereafter, cells were grown in Roswell Park Memorial Institute-1640 media 
containing HEPES (RPMI)(Life Technologies, UK)  10% FBS and 1% G, P/S. 
Passage number was <20. Experiments were conducted using RPMI containing 2% 
FBS and plates were coated with collagen type I from calf skin (Sigma Aldrich, 
Poole, UK).  
RPMI2650 cells are nasal epithelial cells isolated from a squamous cell carcinoma 
from the nasal septum. For this study the cells were obtained from LGC Standards 
(UK). Cells were grown in DMEM with 10% FBS and 1% PSG. Passage number 
was <20 for all experiments. Experiments were conducted using incomplete media 
as described for the A549 cells. All cells were grown at 37°C and supplemented with 
5% CO2. 
The virulent type 2 S. pneumoniae encapsulated strain D39 (NCTC 7466) was 
purchased from the National Collection of Type Cultures (Central Public Health 
Laboratory, UK)  and grown in liquid culture brain heart infusion (BHI) broth (Oxoid, 
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UK) in a water bath, set to 37°C, to mid-logarithmic phase (optical density600=0.4-
0.6) prior to use in vitro.  
To determine the OD600 at which the bacteria are in mid-log phase, bacterial stocks, 
stored at -80°C in BHI containing 10% glycerol, were grown over a period of 4 hours 
and the OD600 measured every 30 minutes. Over the OD600 range of 0.3 to 0.7, the 
change in OD600 is exponential. The concentration of pneumococci over this range 
was determined using quantitative bacterial culture and is approximately 109 
CFU/ml. Quantitative bacterial culture was carried out using BHI agar plates, 
containing 5% horse blood, incubated overnight at 37°C and supplemented with 5% 
CO2. 
2.2 Weld fume collection and analysis 
Samples of mild steel and stainless steel welding fumes for use in vitro and in the 
intranasal inoculation model in vivo, as detailed later in this chapter, were a kind gift 
from Geoff Melton (The Welding Institute, UK). Fume samples were captured in 
accordance with BS EN ISO 15011-1:2009. ‘Health and safety in welding and allied 
processes. Laboratory method for sampling fume and gases.  Determination of 
fume emission rate during arc welding and collection of fume for analysis.’149  
Electrodes were run to produce a weld bead inside the fume collection system.  
Fume was extracted through the hood on top of the box and collected on a filter 
paper. This fume sample was then digested in nitric/hydrochloric acid in a high 
temperature closed vessel microwave assisted dissolution system prior to analysis 
by Inductively Coupled Plasma – Atomic Emission Spectroscopy (ICP-AES). Both 
samples are from manual metal arc (MMA) welding electrodes. Metal analysis of the 
samples showed that the major components of the stainless steel fume were 
potassium, silicon, chromium, manganese and iron. The major components of the 
mild steel fume were potassium, calcium, manganese, magnesium and iron. The 
compositions of the two types of welding fumes provided by Geoff Melton are shown 
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in Table 1. The compositions were supplied by Geoff Melton along with the WF 
samples. 
 Stainless Steel (% of total 
weight of sample) 
Mild Steel (% of total 
weight of sample) 
Aluminium 0.7 0.3 
Barium <0.1 <0.1 
Bismuth <0.1 <0.1 
Calcium 0.7 8.9 
Cobalt <0.1 <0.1 
Chromium 4.1 <0.1 
Copper <0.1 <0.1 
Iron 3.9 12.4 
Potassium 27.4 23.6 
Lithium <0.1 0.4 
Magnesium 0.1 5.3 
Manganese 2.7 3.8 
Molybdenum <0.1 <0.1 
Sodium 3.0 2.6 
Nickel 0.3 <0.1 
Lead 0.1 <0.1 
Silicon 8.8 2.1 
Titanium 1.5 0.6 
Vanadium <0.1 <0.1 
Zinc 0.3 0.2 
Fluoride ions 17.4 17.9 
Chromium (VI) 3.1 <0.1 
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Table 1: Compositions of the mild steel and stainless steel welding fumes used in 
the in vitro and intranasal inoculation in vivo experiments detailed later on in this 
chapter. Each element is represented as a percentage of the total weight of the 
sample provided. The welding fumes were suspended in PBS for use in 
experiments. 
The composition of the stainless steel welding fumes used in the inhalation in vivo 
model, detailed later on in this chapter, was kindly provided by Patti Erderly (Centre 
for Disease Control, USA) and is shown in Table 2. The major components of the 
welding fume sample were iron, chromium, manganese, nickel and copper. The 
particle diameters were less than 10μm. 
 
Stainless Steel (% of total weight of 
sample) 
Iron 57 
Chromium 20.2 
Manganese 13.8 
Nickel 8.8 
Copper 0.2 
Silicon Trace 
Aluminium Trace 
Vanadium Trace 
 
Table 2: Compositions of the mild steel and stainless steel welding fumes used in 
the inhalation in vivo experiments detailed later on in this chapter. Each element is 
represented as a percentage of the total weight of the sample provided. 
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2.3 Pneumococcal adhesion to lower airway epithelial cells  
 The final optimised pneumococcal adhesion assay used is outlined later in this 
section. However, initial work focused on optimising the assay.  
In initial experiments, 2X105 epithelial cells/ml were seeded on 24 well plates and 
left overnight to adhere before use. However, it was found that cells seeded at this 
concentration did not reach 80% confluence overnight. Hence, 4x105 cells/ml were 
grown to confluence overnight on 24 well plates for experiments.  
A previous study in the lab assessed pneumococcal adhesion and invasion of lower 
airway epithelial cells using a multiplicity of infection (MOI) of 240086. Hence, these 
conditions were used in initial experiments. However, a large amount of variability 
was seen when using an MOI of 2400.  
Thus the MOI used was titrated down to 100. It was found that using a lower MOI 
produced tighter and more robust data. 
After optimisation of the assay, the following protocol was used for further 
experiments. Cells were exposed to welding fume in suspension in phosphate 
buffered saline (PBS) made up to the required concentration in incomplete media 
for 2 hours or overnight, washed with incomplete media and infected with S. 
pneumoniae at a multiplicity of infection (MOI) of 100.  Bacteria were allowed to 
grow for between 2.5 to 3 hours, till they entered the mid-log growth phase, before 
use in experiments. Optical density was monitored 2 hours onwards. Prior to use in 
experiments the bacteria were washed 3 times in endotoxin free PBS (Lonza, 
Switzerland) and made up to OD600=0.4-0.6 in PBS. In this OD600 range the 
concentration of the pneumococci is approximately 109 colony forming units 
(CFU)/ml. They were then diluted in incomplete cell culture media to give an MOI of 
100 in experiments. Exposure to incomplete media alone, instead of WF, was used 
as a control. Cells were vigorously washed in incomplete media, detached and 
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lysed using sterile distilled water. Serial dilutions of the samples were plated on 
brain heart infusion agar containing 5% horse blood (Oxoid, UK) in order to assess 
colony forming units (CFU)/ml. 
In order to assess the role of PAFR in adhesion, a PAFR blocker, CV-3988150,151 
(Sigma Aldrich, Poole, UK), was used at a final concentration of 20µM. A 
concentration of 10µm was used for previous work in the lab because BEAS-2B 
cells grown in DMEM did not tolerate a higher dose of CV-3988 and started to lift 
off. However, it was found that changing the culture conditions of these cells by 
culturing them in RPMI, as described above, allowed the use of a higher dose of 
CV-3988 which also produced more robust data. Stock solutions of CV-3988 were 
made up in dimethyl sulfoxide (DMSO). The blocker was added during exposure of 
the cells to the welding fume.  
The effect of N-acetyl cysteine (NAC) (Sigma Aldrich, UK), which is an anti-oxidant, 
on adhesion was also assessed. NAC has been shown to replenish levels of the 
biological anti-oxidant, glutathione152. Stock solutions of NAC were made up in 
distilled water. NAC was used at a final concentration of 5mM. This dose was 
titrated down from a dose of 30M which was used in previous work in the lab. NAC 
was added during the exposure of the cells to the welding fume. 
2.4 Viral infection of lower airway epithelial cells 
Human rhinovirus subtype A, serotype 16 (RV-16), 2X107 tissue culture infective 
dose (TCID50/ml), was a kind gift from Michael Edwards (Imperial College London, 
UK). Infection of A549 and BEAS-2B cells was carried out as described 
previously36. Briefly, 4X105 cells were grown overnight in 24 well plates. Cells were 
infected with virus at MOI 1 or exposed to virus inactivation/filtration controls for 1 
hour, ± 25µg/ml iota carrageenan41, in incomplete media. After 1 hour all virus 
containing media was replaced with incomplete media before proceeding with the 
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experiment. For iota carrageenan treated cells, 25 µg/ml IC was added back to the 
cells and left overnight. An adhesion assay was then carried out as described 
above. 
For the filtration control, virus particles were removed from inocula by ultrafiltration 
through membranes (Amikon, UK) to remove all molecules greater than 30 kDa, 
performed according to the manufacturer’s instructions. For the inactivation control, 
viruses were inactivated by exposure to UV light at 1200 mJ/cm2 for 30 min. 
2.5 Analysis of mRNA levels of genes of interest 
RNA was extracted from either cells or tissue using the RNAeasy kit (Qiagen, UK). 
First strand cDNA synthesis was carried out using SuperScript VILO MasterMix (Life 
Technologies, UK). Real time polymerase chain reactions (RT-PCRs) were carried 
out using TaqMan Gene Expression MasterMix (Life Technologies, UK). mRNA 
analysis was carried out using relative quantification involving normalisation to the 
housekeeping gene. Primer/probe sets used: human housekeeping gene 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) Hs02758991_g1; human 
PAFR Hs00265399_s1; human ICAM-1 Hs00164931_m1; mouse housekeeping 
gene β2 microglobulin Mm00437762_m1; mouse PAFR Mm02621061_m1 (Life 
Technologies, UK), all primer/probe sets spanned exon-exon boundaries to control 
for genomic DNA contamination; information about viral RNA primers and probe 
was taken from a previous study36. All techniques were carried out according to 
manufacturer’s instructions.  
2.6 Imaging methods 
A549 cells exposed to 275µg/ml mild steel welding fume were imaged by Dr. Ann 
Wheeler (Queen Mary University of London, UK) using phase contrast microscopy. 
Images were taken on a time lapse microscope using a 10x objective. The camera 
used was EXI Blue (Photometrics, UK).  
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PAFR protein expression, in vitro, after exposure to welding fumes was measured 
using fluorescence microscopy. Images were taken on a Leica MM DM400 epi-
fluorescence microscope using a 40x oil objective. The camera used was QIQuick 
(QImaging, UK). Images were analysed using ImageJ software (Bethesda, 
Maryland, USA). 4X105 cells were grown on coverslips in 24 well plates. After 
exposure to welding fumes, as described previously, the cells were fixed in ice cold 
4% paraformaldehyde for 10mins at room temperature. The cells were washed 3 
times with PBS+10% FCS (wash buffer). Mouse anti-human PAFR immunoglobulin 
2a (IgG2a) antibody (1:100, CAY160600, Cayman Chemicals, USA) was left on 
overnight at 4°C. A mouse IgG isotype control was used (Biolegend, UK). The cells 
were washed 3 times with wash buffer and an Alexa-fluor 488 conjugated goat anti-
mouse antibody applied (1:2000, Invitrogen, UK) at room temperature for 30mins 
under aluminium foil. The cells were washed 3 times with wash buffer and the 
nuclear stain, 4',6-diamidino-2-phenylindole, dilactate (DAPI), applied (1:1000, 
Invitrogen, UK) at room temperature for 15mins under aluminium foil. The cells were 
washed 3 times with wash buffer and the coverslips mounted on glass slides and 
sealed using transparent nail varnish. The slides were left to air dry under foil for 4 
hours and stored overnight at 4°C for analysis. All antibodies and DAPI were made 
up in wash buffer. 
2.7 Immunohistochemistry 
PAFR protein expression and localisation was visualised using 
immunohistochemistry.  
Antigen retrieval was carried out on 3µm paraffin wax embedded sections dried 
down overnight at 60°C. Slides were placed in an ethylenediaminetetraacetic acid 
(EDTA) buffer of pH8.1 and microwaved at full power for 35 min. The slides were 
then transferred to a DAKO Autostainer where they were treated with a 3% 
peroxidase block followed by the Vector R.T.U Vectastain Kit (PK-7200), according 
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to manufacturer’s recommendations. The working dilution of the human anti-PAFR 
monoclonal antibody CAY160600 (Cayman Chemical, Cambridge Bioscience, UK) 
was 1:100 or rabbit anti-mouse polyclonal antibody BS1478R (Bioss Inc, USA) was 
used at 1:100 and the incubation time was 40 min. The signal was visualised using 
DAKO DAB + Chromogen solution (K3468) applied for 5 min. A Gills haematoxylin 
nuclei counterstain was used for 2 min and differentiated accordingly. A negative 
control using tonsil tissue without the anti-PAFR antibody showed no non-specific 
DAB signal. 
The slides were imaged using an MBF stereology microscope and an Optonics 
camera, using a 10x air objective.  
2.8 Analysis of cell viability 
Analysis of cell viability was carried out using the lactate dehydrogenase (LDH) 
assay (Sigma Aldrich, Poole, UK) according to manufacturer’s instructions. 
Membrane integrity of the cells was measured using the LDH release format of the 
assay. Distilled water was used as a positive control for cell viability. 
2.9 In vivo work 
2.9.1 Welding fume intranasal inoculation model 
Experiments, approved by UCL Biological Services Ethical Committee and UK 
Home Office (Project Licence PPL70/6510), were performed according to UK 
national guidelines for animal use and care, under the UK Home Office licence in 
accordance with EU Directive 2010/63/EU. 
4-6 week old female CD1 mice (Charles River, UK) were used. The mice were 
inoculated intra-nasally, under anaesthesia (isofluorane) with mild steel welding 
fume/5x106 bacteria in 50µl PBS. Control mice received 50µl PBS. The bacterial 
stock stored at -80°C was defrosted and resuspended in PBS before delivery. The 
mice were culled using an overdose of pentobarbital, for assessment of CFU in the 
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blood, lung and bronchial lavage fluid (BALF) and for cell count and cytospin 
analysis of the BALF. PAFR mRNA expression levels in the lung were also 
assessed. 
Intervention regimes for this model are shown in Table 3. 
Table 3: programme of intervention for instillation mouse model: (A) acute exposure 
to WF; (B) chronic exposure to WF; (C) for immunohistochemistry analysis. 
A: acute exposure to WF; total dose of WF=600µg/mouse 
Day Intervention 
1 WF/PBS 
2 Bacteria 
3 Cull 
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B: chronic exposure to WF; total low dose of WF=600µg/mouse 
Day Intervention 
1 WF/PBS 
3 WF/PBS 
5 WF/PBS 
8 WF/PBS 
9 WF/PBS 
10 WF/PBS 
11 Bacteria 
12 Cull 
C: Exposure regime for immunohistochemical analysis; total dose of 
WF=600µg/mouse 
Day Intervention 
1 WF/PBS 
2 WF/PBS 
3 Bacteria 
4 Cull 
2.9.2 Welding fume inhalation model 
Male C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) were used in this study. 
All procedures and protocols were approved by the Animal Care and Use 
Committee of the National Institute for Occupational Safety and Health.  Mice (6 
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weeks of age) were exposed by whole-body inhalation, in individual steel mesh 
cages, to aerosols generated during GMA-SS welding for 10 days at a target 
concentration of 40 mg/m3 for 3 hr/day153. The mice were culled and whole lungs 
removed for mRNA analysis.  
 
The intervention regime for this model is shown in Table 4. 
Table 4: programme of intervention for inhalation mouse model. 
 
Day Intervention 
1 Air/WF (40mg/m3 3hrs) 
2 Air/WF (40mg/m3 3hrs) 
3 Air/WF (40mg/m3 3hrs) 
4 Air/WF (40mg/m3 3hrs) 
5 Air/WF (40mg/m3 3hrs) 
6 Air/WF (40mg/m3 3hrs) 
7 Air/WF (40mg/m3 3hrs) 
8 Air/WF (40mg/m3 3hrs) 
9 Air/WF (40mg/m3 3hrs) 
10 Air/WF (40mg/m3 3hrs) 
11 Cull 
 
RNA was isolated from whole lung homogenates using TRIzol (Invitrogen, USA) 
and then cleaned according to the manufacturer’s instructions using an RNeasy 
Mini Kit (Qiagen, USA). A 2 μl aliquot of each RNA sample was quantified using a 
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, USA). RT-PCR 
reactions were carried out as follows: Evaluation of gene expression was done 
using StepOne™ (Applied Biosystems, USA) with pre-designed Assays-on-Demand 
TaqMan probes and primers (Applied Biosystems). Using 96 well plates, 1μg of total 
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RNA was reverse transcribed using random hexamers (Applied Biosystems) and 
Superscript III (Invitrogen, USA). Hypoxanthine-guanine phosphoribosyltransferase 
was used as an internal reference. Relative gene expression was calculated using 
the ΔΔCt method. 
2.10 Human model of experimental rhinovirus infection 
Endobronchial biopsies were obtained from an experimental RV infection study that 
recruited human volunteers in London (UK). The biopsies were taken from the lower 
lobe subcarinae and were snap frozen in liquid nitrogen and stored at -700C for 
analysis of PAFR mRNA. Data on bacterial infection, symptoms and antimicrobial 
peptides have been previously reported60. Three groups were studied; i) healthy 
non-smokers (controls), ii) smokers without airway obstruction, and iii) smokers with 
moderate COPD (Gold stage II). Bronchoscopy, endobronchial biopsy, 
bronchoalveolar lavage, and induced sputum were carried out at baseline before 
human rhinovirus subtype A, serotype 16 (RV-16) inoculation. Endobronchial biopsy 
was repeated on day 7 after RV inoculation. Informed consent was obtained from all 
subjects (Research Ethics Committee approval 07/H0712/138, and 11/LO/0400). 
Rhinovirus infection was assessed by the recruitment team and infection with 
viruses other than RV was excluded.  
2.11 Statistical analysis  
Unless otherwise stated, data are expressed as means from at least 3 separate 
experiments. 
Data are analysed using GraphPad Prism version 5.03 (GraphPad Software, La 
Jolla, California, USA). All cell work was analysed using parametric tests. Single 
comparisons were carried out using t tests, multiple comparisons were carried out 
using 1 way ANOVA followed by Bonferroni’s multiple comparison test. All animal 
work was analysed using non-parametric tests. Single comparisons were done by 
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Mann Whitney U test and multiple comparisons done by Kruskal-Wallis test followed 
by Dunnett’s multiple comparison test. Paired analyses were carried out using 
paired t tests. In chapter 6, the data set used passed the normality test and hence 
parametric tests were used, as described above, for analyses. A p value <0.05 was 
considered significant. 
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Chapter 3: Exposure of lower 
airway epithelial cells to welding 
fumes and susceptibility to 
adhesion and invasion by 
Streptococcus pneumoniae 
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3.1 Introduction and aims 
Epidemiological studies have shown an increased risk of pneumonia and 
pneumococcal bacteraemia in welders of working age. This increased risk was not 
seen in retired welders4,144. However, the molecular mechanisms by which exposure 
to welding fumes (WF) increases susceptibility to pneumococcal pneumonia are 
unknown.  
As reviewed in chapter 1, the first step in the pathogenesis of pneumococcal 
pneumonia is the adherence of the pneumococcus to airway epithelial cells. This 
adherence is mediated by adhesins on the pneumococcal surface such as ChoP. 
ChoP binds PAFR on the surface of human cells and thus co-opts the receptor for 
pneumococcal entry into the cells8. Previous work in our lab showed that exposure 
to PM10 and CSE causes an increase in PAFR-dependent adhesion to and invasion 
of lower airway epithelial cells86,123.  
It has been shown that exposure of lower airway epithelial cells to welding fume, in 
vitro, caused an increase in ROS produced and a decrease in intracellular 
glutathione. Further, previous work in our lab showed that the anti-oxidant, N-acetyl 
cysteine (NAC), attenuated PM10 exposure-induced pneumococcal adhesion and 
invasion of lower airway epithelial cells86. This suggests that apart from PAFR, 
oxidative stress mechanisms may also be involved in particulate matter induced 
pneumococcal adhesion and invasion of these cells. 
Hence, the questions I sought to address were: 
 Are airway epithelial cells exposed to welding fume more susceptible to 
pneumococcal invasion and adhesion? 
 Is increased susceptibility PAFR-dependent? 
 Does oxidative stress play a role in increased susceptibility? 
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3.2 Results 
3.2.1 Exposure of A549, BEAS-2B and RPMI2650 cells to welding fume and 
pneumococcal adhesion and invasion  
In order to assess whether exposure to welding fumes increases susceptibility of 
lower airway cells to adhesion and invasion by pneumococci A549 and BEAS-2B 
cells were exposed to different doses (50-400µg/ml) of mild steel (MS) and stainless 
steel (SS) welding fumes (WF). The fumes were then washed off and the cells 
infected with S. pneumoniae strain D39 at an MOI of 100. Using data from these 
experiments optimal doses of welding fume for each cell line were chosen for future 
work. The number of adherent and invaded bacteria for each dose of welding fume 
was compared to the control using an unpaired t test in order to determine the 
lowest dose at which statistical significance was observed. 
Exposure of A549 and BEAS-2B cells to welding fume increased pneumococcal 
adhesion and invasion of these cells in a dose dependent manner (figure 1). In 
A549 cells exposed to mild steel WF the lowest dose at which significance was 
seen, compared to the control using an unpaired t test, was 300µg/ml (*p<0.05, 
figure 1A). For A549 cells exposed to stainless steel WF this dose was 200µg/ml 
(*p<0.05, figure 1C). In A549 dose response experiments with mild steel WF (n=4) 
some changes in cell morphology, i.e loss of adherence of the cells, were seen in 
cells exposed to mild steel WF at a dose of 300µg/ml (n=1). Hence, 275µg/ml was 
chosen as optimal dose for additional experiments in A549 cells. In BEAS-2B cells 
exposed to mild steel WF the lowest dose at which a significant increase in bacterial 
adhesion and invasion was seen, compared to the control using an unpaired t test, 
was 200µg/ml (**p<0.01, figure 1B). In BEAS-2B cells exposed to stainless steel 
WF this dose was 50µg/ml (*p>0.05, figure 1D). Hence, a dose of 200µg/ml dose 
was chosen for further experiments. 
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Maximum pneumococcal adhesion and invasion seen was higher in A549s 
(approximately 5500 CFU/ml) compared to BEAS-2Bs (2000 CFU/ml). 
 
Figure 1: Pneumococcal adhesion and invasion of (A) A549 cells exposed to mild 
steel WF (B) BEAS-2B cells exposed to mild steel WF (C) A549 cells exposed to 
stainless steel WF, and (D) BEAS-2B cells exposed to stainless steel WF. Data are 
from at least 3 separate experiments and are expressed as averages from at least 4 
wells/experiment. Data are compared to the control using unpaired t tests and 1 way 
ANOVA followed by Dunnett’s multiple comparison test. 
 
Nasal carriage of S. pneumoniae is high in the general population and translocation 
of pneumococci across the nasal epithelial barrier may lead to bacterial invasion of 
the blood stream. Hence, it was considered important to assess the effect of 
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exposure to WF on pneumococcal adhesion to and invasion of nasal epithelial cells 
and thus susceptibility to pneumococcal disease.  
The cells were exposed to a range of doses (10-300µg/ml) of mild steel welding 
fume. The WF was then washed off and the cells infected with S. pneumoniae. The 
cells were then lysed and adherent and invaded pneumococci analysed.  
Using an unpaired t test it was found that the lowest dose at which a significant 
increase in adhesion and invasion was observed compared to the control was 
200µg/ml (*p<0.05). However, since no changes in cell morphology were seen at 
300µg/ml, this dose was used in future experiments (figure 9). The maximum 
stimulation of pneumococcal adhesion and invasion seen in these experiments was 
approximately 3500 CFU/ml which is higher than that seen in BEAS-2B (2000 
CFU/ml) cells but lower than that seen in A549 cells (5500 CFU/ml). 
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Figure 2: Pneumococcal adhesion and invasion of nasal epithelial cells after 
exposure to a range (50-300µg/ml) of doses of mild steel welding fume. 
Pneumococcal adhesion and invasion to these cells increased in a dose-dependent 
manner after exposure to the WF. The lowest dose at which a significant increase in 
pneumococcal adhesion and invasion was seen compared to the control was 
200µg/ml. Data are from two separate experiments. Each data point represents a 
single sample. Data were compared using unpaired t tests and a 1 way ANOVA 
followed by Dunnett’s multiple comparison test. 
 
The welding fume dust was in suspension in PBS and was diluted down to a 
concentration of 275µg/ml in complete media as described in the methods chapter 
of this thesis. Each particle of WF is less than 10µm in diameter. The WF coats the 
cells (figure 3) with some larger clumps being formed. No morphological changes 
were seen after the cells were exposed to WF at this dose for 2 hours. 
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Figure 3: Phase contrast microscopy images of A549 cells (A) grown in complete 
media, (B) exposed to 275ug/ml mild steel welding fume. The welding fume coats 
the cell monolayer with some larger clumps of particulate matter being formed. 
 
The effect of exposure to mild steel welding fume on bacterial growth was also 
assessed by growing the bacteria in the presence and absence of welding fume. 
CFU/ml was assessed after 3hours, using quantitative bacterial culture. A decrease 
in bacterial growth was observed in pneumococcal stocks grown in welding fume for 
3h, compared to the control (figure 4). However, this decrease was not significant. 
The dose of WF used in this experiment is the highest dose used throughout the 
studies presented in this thesis i.e 300µg/ml. 
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Figure 4: Effect of 3h exposure to WF on bacterial growth. CFU/ml observed after 
pneumococcal growth in WF from stocks stored at -80°C was lower compared to the 
control. However, the difference in CFU/ml was not significant. Data are from 4 
separate experiments and are compared using a paired t test. 
3.2.2 WF and viability of cells  
Cell viability over the range of WF doses used in this study was measured using 
lactate dehydrogenase (LDH) leakage into the media (figure 5). LDH is a marker of 
tissue damage. This was done to check whether bacterial adhesion and invasion of 
the cells after exposure to WF could be attributed to loss of membrane integrity of 
these cells. 
No significant effect on cell viability was seen. Distilled water was used as a positive 
control for cell viability because it anti-oxidantlyses cells by osmotic shock.  
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Figure 5: Cell viability effects after exposure to welding fume. Mild steel welding 
fume exposure in (A) A549s (B) BEAS-2Bs, and stainless steel WF exposure in (C) 
A549s (D) BEAS-2Bs. Data are from single experiments. In each experiment data 
from 3 wells are expressed.  
3.2.3 Role of oxidative stress in mediating WF-simulated pneumococcal 
adhesion 
The anti-oxidant, NAC, was used to assess the role of oxidative stress in WF 
stimulated pneumococcal adhesion and invasion of lower airway epithelial cells. 
Exposure to WF causes oxidative stress in lower airway epithelial cells and hence 
an increase in oxidative stress may contribute to increased susceptibility of these 
 71 
 
cells to pneumococcal adhesion and invasion. NAC replenishes glutathione stores. 
Glutathione is a biological antioxidant. The cells were exposed to either NAC alone, 
WF alone or NAC + WF for 2 hours before infection with S. pneumoniae.  
WF-stimulated pneumococcal adhesion was attenuated by treatment with NAC 
during exposure of the cells to welding fume (figure 6). A low level of basal adhesion 
and invasion was seen in the control cells and was also observed in cells exposed 
to NAC. A significant increase in pneumococcal adhesion and invasion was seen in 
cells exposed to WF alone compared to the control in all experiments. A significant 
decrease in adhesion and invasion was seen in cells exposed to NAC + WF 
compared to cells exposed to WF alone in all experiments. 
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Figure 6: Treatment of cells with NAC during exposure to welding fume causes an 
attenuation of welding fume-stimulated pneumococcal adhesion to and invasion of 
lower airway epithelial cells. NAC attenuated mild steel WF-stimulated adhesion to 
cells in (A) A549s (**p<0.01) (B) BEAS-2Bs (***p<0.001), and stainless steel 
exposure-stimulated pneumococcal adhesion in (C) A549s (***p<0.001) (D) BEAS-
2B cells (***p<0.01). In all experiments, a significant increase in adhesion and 
invasion was seen after exposure to WF compared to control. Data are from 3 
separate experiments and are expressed as means from >4 wells from each 
experiment. Data are compared using 1 way ANOVA followed by Bonferroni’s 
multiple comparison test. 
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3.2.4 Role of PAFR in mediating WF-simulated pneumococcal adhesion 
A specific PAFR blocker, CV-3988, was used to assess the role of PAFR in WF-
stimulated pneumococcal adhesion and invasion of lower airway epithelial cells. The 
hypothesis was that since CV-3988 binds PAFR it would block the interaction 
between PAFR and ChoP on the pneumococcal surface and thus prevent the 
internalisation of pneumococci via PAFR. The cells were exposed to either 20µM 
CV-3988 alone, WF alone or CV-3988 + WF for 2 hours. The blocker was washed 
off before pneumococcal infection.  
WF-stimulated pneumococcal adhesion was attenuated by treatment with CV-3988. 
A low level of basal adhesion and invasion seen in the control cells was also 
observed in cells treated with CV-3988. In all experiments a significant increase in 
pneumococcal adhesion and invasion was seen after WF stimulation, compared to 
the control. A significant decrease in pneumococcal adhesion and invasion was 
seen in cells exposed to WF + CV-3988 compared to cells exposed to WF alone 
(figure 7). 
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Figure 7: Treatment with CV-3988 during exposure of cells to weld fume causes an 
attenuation of weld fume-stimulated pneumococcal adhesion to the cells. CV-3988 
attenuated mild steel WF exposure-stimulated pneumococcal adhesion in (A) A549s 
(**p<0.01) (B) BEAS-2B cells (***p<0.001), and stainless steel exposure-stimulated 
pneumococcal adhesion in (C) A549 cells (***p<0.001) (D) BEAS-2Bs (***p<0.001). 
In all experiments, a significant increase in adhesion and invasion was seen after 
exposure to WF compared to control. Data are from 3 separate experiments and are 
expressed as means from >4 wells from each experiment. Data are compared using 
1 way ANOVA followed by Bonferroni’s multiple comparison test. 
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It was also considered important to test whether PAFR has a role in WF-induced 
pneumococcal adhesion and invasion to nasal epithelial cells. In order to do this the 
cells were exposed to CV-3988, a PAFR blocker, concurrent to WF exposure in the 
adhesion assay outlined above and in the methods chapter of this thesis. 
Exposure of nasal epithelial cells to CV-3988 concurrent to WF-exposure attenuated 
WF-induced pneumococcal adhesion and invasion of the cells (figure 8, **p<0.01). 
As with the A549 and BEAS-2B cells, a low level of basal adhesion and invasion 
was seen in the control cells, which was not attenuated by treatment with CV-3988 
alone. 
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Figure 8: Concurrent treatment of cells with WF and CV-3988 attenuated WF-
induced pneumococcal adhesion and invasion to nasal epithelial cells (n=3, 
***p<0.001). Each data point is the mean of at least 4 samples and represents a 
single experiment. The data were compared using 1 way ANOVA followed by 
Bonferroni’s multiple comparison test. 
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3.2.5 WF and PAFR mRNA expression 
Since previous data showed a role of PAFR in WF-stimulated pneumococcal 
adhesion and invasion, PAFR expression levels, after a 2hour WF exposure, were 
studied at the mRNA level. It was hypothesised that PAFR mRNA is upregulated 
after WF exposure which increases susceptibility to pneumococcal infection. 
PAFR mRNA expression was measured after exposure to WF. For each sample 
PAFR mRNA expression was measured relative to the housekeeping gene, 
GAPDH. Each data point represents a single experiment and is the average of at 
least 2 samples. Expression levels were measured using TaqMan primers and 
probes and the ΔΔCt method.  
An increase in PAFR expression was only seen in A549 cells after exposure to mild 
steel WF. No change in mRNA levels was seen in A549 cells after exposure to 
stainless steel WF or in BEAS-2B cells after exposure to either type of WF (figure 
9).  
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Figure 9: mRNA expression of PAFR after exposure to WF. In (A) an increase was 
seen in A549 cells after exposure to mild steel WF (**p<0.01). No significant change 
in expression was seen in (B) A549 cells after exposure to stainless steel WF or in 
BEAS-2B cells after exposure to (C) mild steel WF or (D) stainless steel WF. Data 
are from at least 2 separate experiments and are expressed as means from at least 
2 samples per experiment. Data are compared using unpaired t tests.   
3.2.6 WF and surface protein expression of PAFR 
Since examining PAFR expression at the mRNA level proved inconclusive and 
PAFR is a surface protein it was important to assess PAFR protein expression on 
the surface of cells after exposure to WF. Since the role of PAFR in WF-induced 
pneumococcal adhesion and invasion was directly assessed using the PAFR 
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blocker, CV-3988, for both types of WF, PAFR protein levels were only assessed in 
both cell types using mild steel WF.  
Surface protein expression of PAFR was measured using immunofluorescence 
microscopy. The cells were exposed to WF for 2 hours. The WF was washed off 
and the cells fixed. A mouse anti-human PAFR primary antibody was used followed 
by an Alexa-fluor 488 secondary antibody. DAPI was used to detect nuclear DNA. 
To check for non-specific staining a mouse isotype control antibody was used 
instead of the primary antibody (figure 10). The green areas seen in the figure are 
most likely clumps of secondary antibody rather than non-specific binding because 
they are not in the immediate vicinity of cells. This experiment showed that 
interactions between the anti-human PAFR antibody and the secondary antibody 
detected by immunofluorescence microscopy were specific. 
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Figure 10: Non-specific binding of the secondary antibody to A549 cells. An isotype 
control was used instead of the primary anti-human PAFR antibody, followed by the 
secondary antibody to check for non-specific binding of the secondary antibody to 
the cells. The nuclei of the cells are stained with DAPI (blue). No secondary 
antibody staining (green) was seen associated with cells which suggests that the 
staining seen is due to clumping of the secondary antibody rather than due to non-
specific interactions between primary (anti-PAFR) and secondary antibodies.  
 
An example of PAFR surface expression in A549 cells in complete media or 
exposed to WF can be seen in figure 11. The images were analysed in a blinded 
manner. A fluorescence intensity threshold was set to discount background 
fluorescence. The area of fluorescence was then measured for each image.  1-3 
images/condition were analysed in each experiment. In the images presented DAPI 
and PAFR staining was merged to show localisation of PAFR. However, for the 
 80 
 
analyses, PAFR staining was measured separately to prevent DAPI staining 
affecting the fluorescence intensity readings. 
A significant increase in PAFR surface expression was seen in A549 cells after 
exposure to mild steel WF (*p>0.05, figure 11A). A trend towards higher expression 
levels of PAFR surface protein was seen in BEAS-2B cells after exposure to mild 
steel WF (p=0.06, figure 11B). An example of the staining observed can also be 
seen in figure 11C and D.  
 
Figure 11A;B: PAFR surface expression in lower airway epithelial cells after 
exposure to mild steel WF. An increase in expression was seen after exposure to 
welding fume, compared to the control in (A) A549 cells (*p<0.05). A trend towards 
higher expression was seen in (B) BEAS-2B cells (p=0.06). Data are from 7 
separate experiments. Data from 1-3 samples per condition were averaged in each 
experiment and each data point represents one experiment. The data were 
compared using paired t tests. The images were analysed using ImageJ software 
and the PAFR stained area of each image was calculated.  
 81 
 
 
Figure 11C: An example of PAFR staining can be seen in control A549 cells The 
white arrow denotes an example of an area of PAFR staining included in the 
analysis.  
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Figure 11D: An example of PAFR staining can be seen in WF exposed A549 cells. 
The white arrows denote examples of areas of PAFR staining included in the 
analysis.  
3.3 Conclusions 
The data show that in A549 and BEAS-2B cells exposure to welding fume increases 
susceptibility to adhesion and invasion by S. pneumoniae in a dose-dependent 
manner. Similar dose response curves were observed for both mild steel and 
stainless steel welding fume. An optimal dose of 275µg/ml for A549 cells and 
200µg/ml for BEAS-2B cells was chosen for further studies, based on the dose 
response data. In this study, cell viability was also measured, using the lactate 
dehydrogenase release assay, over the range of doses used. No effect on cell 
viability after exposure to either type of WF was seen in either cell line. This is 
contrary to a previous report that exposure to stainless steel WF caused a decrease 
in cell viability at doses above 63µg/ml141. Cell viability in the study was measured in 
 83 
 
A549 cells using a similar assay to that used for this thesis141. This observation 
highlights the importance of evaluating the effects of the different components of the 
WF on airway epithelial cell biology.  
CV-3988, which binds PAFR and thus blocks its interaction with ChoP on the 
surface of pneumococci, was used to show that the increased susceptibility to 
pneumococcal invasion and adhesion after exposure to WF is PAFR-dependent. 
This observation is consistent with previous studies conducted in our lab which 
showed that PAFR is a key receptor involved in increased susceptibility to S. 
pneumoniae adhesion to lower airway epithelial cells after exposure to PM10 and 
CSE86,123. However, it was observed that a low level of basal adhesion and invasion 
occurred in spite of treatment with CV-3988. This basal adhesion and invasion was 
also seen in the control cells8,43. This suggests that there may be some yet unknown 
PAFR-independent mechanisms involved in this process. Further work is required to 
provide clues about what these mechanisms may be. 
Exposure to WF has been shown to cause oxidative stress in lower airway epithelial 
cells. Further, previous work in our lab showed that an attenuation of oxidative 
stress, caused by exposure to PM10, by NAC caused an attenuation of S. 
pneumoniae invasion of lower airway epithelial cells86. Additionally, it has been 
shown that NAC attenuated increased ROS production by bronchial epithelial cells 
after exposure to PM68 and injury caused by cigarette smoke in murine alveolar 
epithelial cells103. Hence, it was hypothesised that an anti-oxidant such as N-acetyl 
cysteine may attenuate WF-stimulated pneumococcal adhesion and invasion of 
lower airway epithelial cells. Indeed treatment of the cells with NAC concurrent to 
WF exposure attenuated WF-stimulated pneumococcal infection. Again, as with the 
use of CV-3988, the basal adhesion and invasion of the cells was not affected by 
treatment with NAC.  
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In A549 cells it was shown that exposure to mild steel welding fume caused an 
increase in mRNA expression of PAFR. These data are consistent with the 
hypothesis that exposure to the welding fume causes an upregulation of PAFR 
expression which in turn leads increased pneumococcal invasion of the cells. 
However, this upregulation of PAFR mRNA was not seen in A549 cells exposed to 
stainless steel welding fume and in BEAS-2B cells exposed to either mild steel or 
stainless steel welding fume. Hence, taken together the PAFR mRNA data were 
inconclusive. PAFR is a surface receptor. PAFR signalling involves rapid 
internalisation after ligand binding and recycling of the receptor. The process of 
transcription is relatively much slower and the mRNA may be quickly translated 
because it is not very stable in the cytoplasm. Further work is required to better 
understand the kinetics of this process. However, for the purpose of this 
investigation it was considered more relevant to study surface protein expression 
instead.  
Using fluorescent microscopy it was shown that exposure to WF significantly 
increases PAFR surface expression in lower airway epithelial cells. Hence, there is 
evidence to support the hypothesis that exposure to WF increases PAFR surface 
expression and thus increases susceptibility to pneumococcal infection in these 
cells. As mentioned earlier, PAFR is rapidly internalised after ligand binding and is 
recycled. The kinetics of this process are poorly understood. Further, very little is 
known about the downstream signalling processes. 
S. pneumoniae is carried asymptomatically in the nasopharynx by a large 
percentage of the population. Translocation of pneumococci across the nasal 
mucosal barrier may lead to pneumococcal bacteraemia. Additionally, PAFR 
expression has previously been observed in nasal epithelial cells11. In light of the 
epidemiological evidence that welders are more susceptible to pneumococcal 
bacteraemia it was considered of importance to assess the effect of exposure of 
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nasal epithelial cells to WF on pneumococcal adhesion and invasion of these cells. 
The data presented earlier in this chapter suggest that exposure to mild steel 
welding fume increases susceptibility of nasal epithelial cells to pneumococcal 
infection. As the nasal epithelial cells responded to WF exposure in a similar 
manner to the A549 and BEAS-2B cells, only one type of WF was tested in these 
preliminary experiments. The data also suggest a role of PAFR in the increased 
susceptibility. This suggests that PAFR expression in nasal cells exposed to WF 
may be a good biomarker for susceptibility to pneumococcal infection in the lower 
airway. To expand on this preliminary work in nasal epithelial cells, it would be of 
interest to examine PAFR expression in the nasal mucosa of welders who have 
recently been involved in welding activity.  
Pneumococcal adhesion to airway epithelial cells is the first step of pneumonia 
pathogenesis. Occupational exposure to welding fume has been shown to increase 
risk of pneumococcal pneumonia. In this study it has been shown that exposure to 
WF increases PAFR expression on the surface of lower airway epithelial cells and 
that blocking PAFR attenuates pneumococcal adhesion and invasion in both upper 
and lower airway epithelial cells. Hence, PAFR may be a putative anti-infective 
target in welders. Further work is required to better understand the kinetics of PAFR 
expression and signalling and to elucidate the mechanisms by which oxidative 
stress plays a role in increased susceptibility of lower airway epithelial cells to 
pneumococcal infection. However, a major limitation of this study is that it was 
carried out using immortalised cell lines. Modification of primary cells or tissue by 
immortalisation causes changes in the genetic and phenotypic characteristics of the 
cells154. Additionally, the study looks at the effect of WF on each type of cell in 
isolation and does not model any complex interactions between cell types or 
between the cells used and other components of the respiratory or immune system, 
such as macrophages. Hence, the data presented in this chapter may not be an 
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accurate representation of what is occurring in vivo. Primary bronchial epithelial 
cells are currently commercially available but could not be used in this study due to 
financial restraints. It is of interest to validate the findings presented in this chapter 
in these primary cells. 
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Chapter 4: Exposure to welding 
fume and susceptibility to 
pneumococcal pneumonia in 
mice 
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4.1 Introduction and aims 
Occupational exposure to welding fume has been shown to increase susceptibility 
to pneumococcal pneumonia. However, biological plausibility has not been 
established. Further, little is known about the mechanisms that confer this increased 
susceptibility.  
It has been shown that rats chronically exposed to welding fumes have increased 
DNA damage in the lungs140 and increased numbers of inflammatory cells such as 
neutrophils and macrophages136,139. Further, it has been shown that rats exposed to 
welding fumes and infected with L. monocytogenes have a higher bacterial 
burden145,153.  
Data presented in chapter 3 showed that increased pneumococcal adhesion and 
invasion of welding fume exposed lower airway epithelial cells is PAFR-dependent 
and that welding fume exposure increased PAFR surface protein expression in 
these cells.  
Hence, this study sought to determine whether the results seen in vitro, outlined in 
chapter 3, translate to a biological effect in vivo. Thus the study had the following 
aims: 
 To establish biological plausibility of increased susceptibility to 
pneumococcal infection after welding fume exposure in a mouse model 
 To assess PAFR expression and localisation in the lungs of welding fume 
exposed mice 
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4.2 Results 
4.2.1 Acute exposure to WF by intranasal inoculation route, S. pneumoniae 
strain: D39 
Mice (n=6/group) were intranasally inoculated with either PBS; mild steel WF; PBS 
+ S. pneumoniae or WF + S. pneumoniae, under anaesthesia. 600µg of WF and 
5X106 S. pneumoniae were used. The total amount of inoculum/mouse was 50µl. 
The amount of pneumococci used was measured using quantitative bacterial 
culture. The mice were culled 24 hours later for analysis of CFU counts in the blood, 
BALF and one lung. The second lung was used for PAFR mRNA analysis. A tabular 
representation of the timing and type of intervention performed is shown below. 
Day Intervention 
1 Intranasal inoculation of PBS+D39/WF+D39 under anaesthesia 
2 Cull 
 
A significant increase in both lung (**p<0.01, figure 1B) and BALF CFU counts was 
observed after exposure to welding fume compared to the control (*p<0.05, figure 
1A). Further, a significantly higher proportion of the leucocyte population found in 
the lungs of mice that received WF alone was neutrophils compared to the PBS 
control (*p<0.05, figure 1C). Similarly, a significantly higher proportion of the 
leucocyte population of the lungs of mice that received WF+bacteria was 
neutrophils compared to those that received PBS+bacteria (*p<0.05, figure 1C). No 
pneumococci were observed in the blood.  
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Figure 1: Exposure to mild steel welding fume increases susceptibility to 
pneumococcal pneumonia in mice (n=6/group). Increased CFU counts were 
observed in (A) BALF and (B) lung. (C) A higher percentage of neutrophils was 
seen also in mice exposed to welding fumes and infected with pneumococci 
compared to those only infected with pneumococci. CFU data are compared using 
Mann-Whitney U tests, neutrophil data are compared by Kruskal-Wallis test followed 
by Dunn’s multiple comparison test. 
 
In the same experiment PAFR mRNA expression levels were assessed using 
TaqMan primers and probes.  Gene expression was measured relative to the 
housekeeping gene and analysed using the ΔΔCt method. RT-PCR reactions were 
carried out in triplicate. 
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 A significant increase in PAFR expression was seen after exposure to WF alone 
(10 fold, *p<0.05) and to WF+bacteria (approximately 7 fold, **p<0.01) compared to 
the PBS control (figure 2).   
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Figure 2: Exposure to welding fume alone and WF+bacteria caused a significant 
increase in PAFR mRNA expression compared to the PBS control (n=6). In infected 
mice, WF exposed mice had significantly higher PAFR mRNA expression compared 
to unexposed mice. Data are compared using Kruskal-Wallis test followed by 
Dunn’s post-test.   
4.2.2 Chronic exposure to WF by intranasal inoculation route, S. pneumoniae 
stain: D39 
To model chronic exposure to welding fumes the following exposure regimen was 
used: 
Monday, Wednesday, Friday of Week 1: either PBS or WF delivered intranasally 
under anaesthesia 
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Monday, Tuesday, Wednesday of Week 2: either PBS or WF delivered intranasally 
under anaesthesia 
Thursday of Week 2: 5x106 S. pneumoniae delivered intranasally under 
anaesthesia. The number of pneumococci present in the inoculum was measured 
using quantitative bacterial culture. 
Friday of Week 2: cull for analysis of CFU counts in blood, BALF and lungs and 
analysis of amounts of macrophages and neutrophils present in BALF. A tabular 
representation of the timing and type of intervention performed is shown below. 
Day Intervention 
1 Intranasal inoculation of PBS/WF under anaesthesia 
3 Intranasal inoculation of PBS/WF under anaesthesia 
5 Intranasal inoculation of PBS/WF under anaesthesia 
8 Intranasal inoculation of PBS/WF under anaesthesia 
9 Intranasal inoculation of PBS/WF under anaesthesia 
10 Intranasal inoculation of PBS/WF under anaesthesia 
11 Intranasal inoculation of D39 under anaesthesia 
12 Cull 
 
For the chronic low dose exposure a total dose of 600µg/mouse of WF was 
delivered in 100µg/mouse instalments.  
There were 6 mice/group. No pneumococci were seen in the blood. A significant 
increase in CFU counts was seen in the BALF (*p<0.05, figure 3A) and lungs 
(*p<0.05, figure 3B) of WF exposed mice compared to the controls. A significantly 
higher proportion of the cells recovered from the BALF were neutrophils in WF 
exposed mice compared to PBS exposed mice (**p<0.01, figure 3C). 
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Figure 3: Chronic exposure to WF increases susceptibility to pneumococcal 
pneumonia. Exposure to WF significantly increased CFU counts in the (A) BALF 
and (B) lungs of WF exposed mice compared to the controls. (C) The proportion of 
BALF cells that were neutrophils were significantly higher in the WF mice compared 
to the controls. Data are from at least 5mice/group. Data are compared using Mann 
Whitney U test. 
 
For the chronic high dose exposure a total dose of 3.6mg/mouse of WF was 
delivered in 600µg/mouse instalments. 
There were 6 mice/group. No BALF was obtained for one WF exposed mouse due 
to a technical error. Further, another WF exposed mouse had to be excluded from 
the analysis due to no CFU counts being seen in either the BALF or the lungs. This 
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may be due to a technical error by which the mouse received no bacteria. The 
cytospin slides were of poor quality and could not be analysed. 
No pneumococci were seen in the blood. A significant increase in CFU counts was 
seen in the BALF (*p<0.05, figure 4A) and lungs (*p<0.05, figure 4B) of WF exposed 
mice compared to the controls.  
 
Figure 4: Chronic high dose exposure to WF increases susceptibility to 
pneumococcal pneumonia. Exposure to WF significantly increased CFU counts in 
the (A) BALF and (B) lungs of WF exposed mice compared to the controls. Data are 
from at least 5mice/group. Data are compared using Mann Whitney U test. 
4.2.3 Chronic exposure to WF using inhalation route; exposure conditions: 
whole body inhalation of stainless steel welding fumes for 10 days at a target 
concentration of 40mg/m3 for 3hours/day 
Patti Erderly (Centre for Disease Control, USA) kindly agreed to mine stored lung 
mRNA from a mouse model of welding fume inhalation for this study. The data 
presented above showed that acute exposure to welding fumes in mice, via 
nasopharyngeal aspiration, caused an increase in pneumococcal infection and in 
PAFR mRNA. Hence, it was considered important to study PAFR mRNA expression 
in the mined samples. A description of the study design is outlined in the methods 
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chapter of this thesis. Briefly, mice (n=4/group) were exposed to stainless steel 
welding fume at a concentration of 40mg/m3 for 3hours/day for 10 days. The mice 
were then culled and PAFR expression in the lung tissue was analysed. Taqman 
primers and probes were used for the RT-PCR reactions and the ΔΔCt method was 
used for analysis of the data. 
 
Study design and experimental procedures were conducted by Patti Ederly at the 
request of the author of this thesis. Data analysis was conducted by the author of 
this thesis. 
 
PAFR mRNA expression was significantly increased (2-fold) 4hours (*p<0.05, figure 
5A) and 28 days (**p<0.01, figure 5B) after the last exposure to welding fumes in 
exposed mice compared to control mice. 
 
Figure 5: PAFR mRNA expression after the last exposure to stainless steel welding 
fumes in a 10day inhalation model of welding fume exposure in mice. A significant 
increase in PAFR mRNA expression was seen (A) 4 hours and (B) 28 days after the 
last exposure to WF compared to air exposed mice. The data are compared using 
unpaired t tests. 
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4.2.4 PAFR expression and localisation after WF exposure 
 Mice (n=3/group) were exposed to a total dose of 600µg/mouse of mild steel WF, 
as described in the methods chapter. The mice were then culled 24 hours later for 
lung immunohistochemical analysis. The images were scored by a blinded operator.  
Immunohistochemical scores for alveolar+bronchial epithelial PAFR staining were 
higher for WF exposed mice compared to control mice (figure 6A). The difference 
was not significant (p=0.11). A qualitative observation of alveolar wall thickening, as 
indicated by the white arrows, was made in mice exposed to WF (figure 6C) which 
was not seen in the controls (figure 6B).  
 
Figure 6A: Immunohistochemical analysis of mouse lungs after exposure to WF. WF 
exposed mice had higher immunohistochemical scores for alveolar+bronchial PAFR 
staining compared to control mice. This difference was not significant. The data are 
compared using a Mann-Whitney U test.  
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Figure 6B: PAFR staining seen in the unexposed mouse lungs.  
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Figure 6C: PAFR staining seen in mouse lungs after exposure to WF. The white 
arrows indicate areas of alveolar wall thickening.  
4.3 Conclusions  
The data show, for the first time, that acute exposure to mild steel welding fume 
increases susceptibility of mice to pneumococcal infection in the lungs. This 
increase in infection is accompanied by an increase in PAFR mRNA expression 
which is consistent with the in vitro protein expression data presented in chapter 3. 
Further, the effect of chronic exposure to WF on susceptibility to pneumococcal 
infection was also studied. An increase in pneumococci in the lungs was seen in this 
exposure model. This is consistent with previous reports that chronic exposure to 
WF followed by infection with L. monocytogenes resulted in increased bacterial 
burdens compared to the controls in rats145,153. These data provide first evidence of 
biological plausibility of susceptibility to pneumococcal infection after exposure to 
mild steel welding fumes. 
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In the intranasal instillation studies presented the pneumococcal stock used was not 
virulent enough to cause pneumococcal invasion into the blood. This may be a 
technical artefact caused by passages of the stock or long term storage at -80°C in 
nutrient broth containing 10% glycerol. However, this may also be because apart 
from exposure to WF there may be other risk factors that contribute to the 
development of invasive pneumococcal disease in welders. Indeed the limited 
epidemiological literature suggests that while welders are at a higher risk of 
developing lobar and bronchopneumonia, smoking is a major confounder in 
studying increased risk of welders to invasive pneumococcal disease4,142–144. Hence, 
the data presented in this study suggest that exposure to welding fumes per se 
increases susceptibility to non-invasive pneumococcal disease in a mouse model. 
A limitation of these studies is that the exposure was via intranasal inoculation 
rather than the physiological route which is inhalation. A dose of 600µg was the 
highest possible tolerated by a single mouse by intranasal inoculation under 
anaesthesia. The only other mouse study in which the WF was delivered in a similar 
way used a total dose of 400µg/mouse delivered in 100µg instalments over 4 
different days134. In the low dose chronic exposure experiment a total dose of 
600µg/mouse was delivered in 100µg instalments over 6 different days. Other 
studies in rats have used a total dose of 2mg/rat139,145,155. The U.S Environmental 
Protection agency recommends a daily exposure limit to particulate matter of 
150µg/m3. However, little is known about the concentration of particulate deposits in 
the lungs after these exposures. Hence, estimating the dose to be delivered by 
nasopharyngeal aspiration in this mouse model is difficult. Thus, it was considered 
of importance to assess PAFR mRNA levels in WF exposed mice using a more 
relevant inhalation model.  
In the welding fume inhalation mouse model, inhalation doses were set at 40mg/m3 
for 3hours/day. After a 10 day exposure period it was found that PAFR mRNA levels 
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were increased in WF exposed mice compared to air exposed mice. PAFR levels 
were measured at both 4hours and 28 days after the last exposure. The study may 
be extended to assess the earliest time point at which PAFR mRNA is upregulated 
and the longest time period over which it is sustained. This may provide clues about 
a window for PAFR-dependent enhanced susceptibility to pneumococcal infection in 
welders which is useful in a clinical context. Further, pneumococcal infection was 
not assessed in the inhalation model and would be interesting to assess in future 
work. Further work could also include the use of a PAFR knockout mouse to better 
understand the role of PAFR in welding fume-dependent increased susceptibility to 
pneumococcal pneumonia. 
Immunohistochemical analysis of PAFR expression showed that the protein is 
expressed by the alveolar and bronchial epithelium. Quantifying expression levels 
showed that WF exposed mice had higher, although not significantly so, levels of 
PAFR in the alveolar and bronchial epithelium compared to control mice (p=0.11). 
Taken with the lung PAFR data, these data suggest that the higher PAFR mRNA 
levels seen in mice exposed to WF through both the instillation and inhalation routes 
may be localised to the bronchial and alveolar epithelium which are putative sites for 
pneumococcal infection. The functional studies using the PAFR blocker, CV-3988, 
in bronchial and alveolar epithelial cells, presented in chapter 3 of this thesis, 
provide functional relevance for these observations in mice. Additionally, alveolar 
wall thickening was also observed in mice exposed to WF compared to the controls. 
However, this observation could not be quantified.  
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Chapter 5: Viral-bacterial 
interactions in lower airway 
epithelial cells exposed to 
welding fume and potential 
therapies 
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5.1 Introduction and aims 
Epidemiological studies have shown that occupational welders are more susceptible 
to viral pneumonia compared to the general population143. However, little is known 
about the molecular mechanisms involved. Viral pneumonia is caused by viruses 
such as rhinoviruses (RVs) and respiratory syncytial virus156,157. A known entry 
receptor for rhinoviruses in human cells is ICAM-132.  
A major cause of fatalities in patients with viral pneumonia, particularly vulnerable 
populations, is secondary bacterial infections. Data from previous chapters 
suggested that welders are more susceptible to pneumococcal pneumonia in a 
PAFR-dependent manner.  
To date there are no effective preventative interventions or cures for rhinovirus 
infections. However, it has recently been shown that a sulphated galactose polymer 
derived from Rhodophyceae seaweed, iota-carrageenan (IC), has anti-rhinoviral 
properties, although the molecular mechanisms involved are unknown41. Further, 
randomised control trials in both adults and children showed that treatment with IC 
caused a reduction in rhinovirus levels in nasal washes39,40. The compound has 
been deemed safe for topical applications and use in food by the U.S FDA. Iota 
carrageenan is also available as an over-the-counter nasal spray for treatment of 
viral colds down to 6 months of age. However, it remains unknown whether iota 
carrageenan is also effective against pneumococcal infections secondary to 
rhinovirus infections. 
Hence, the aims of this study were: 
 To assess ICAM-1-dependent increased susceptibility to rhinoviral infection 
in lower airway epithelial cells after exposure to welding fumes. 
 To test whether exposure to welding fume followed by rhinoviral infection 
increases susceptibility to pneumococcal infection in these cells. 
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 To examine the role of PAFR in rhinoviral/pneumococcal interactions in 
welding fume exposed lower airway epithelial cells  
 To study the effect of IC on rhinoviral/pneumococcal interactions in lower 
airway epithelial cells 
5.2 Results  
5.2.1 Exposure to mild steel welding fumes causes an upregulation of ICAM-1 
mRNA 
A549 and BEAS-2B cells were exposed to mild steel welding fume for 2hours at the 
doses chosen based on the dose response data presented in chapter 3, i.e 
275µg/ml for A549s and 200µg/ml for BEAS-2Bs. ICAM-1 mRNA levels were 
assessed relative to the housekeeping gene, using TaqMan primers and probes. 
The data were analysed using the ΔΔCt method.  
Exposure of both A549s (78-fold, ***p<0.01, figure 1A) and BEAS-2Bs (10-fold, 
***p<0.01, figure 1B) to mild steel welding fume caused a significant upregulation of 
ICAM-1 mRNA expression.  
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Figure 1: mRNA expression of ICAM-1 after exposure to mild steel welding fumes. 
Exposure caused an upregulation of ICAM-1 mRNA expression in (A) A549s 
(*p<0.05), and (B) BEAS-2B cells (*p<0.05). Data are from two separate 
experiments and are expressed as means of 4 samples per experiment. For each 
sample, mRNA from three separate wells was pooled for analysis. RT-PCR 
reactions were carried out in triplicate. Data are compared by unpaired t tests. 
 
The cells were exposed to stainless steel WF at the same doses as those 
mentioned above for each cell line. ICAM-1 mRNA analysis was carried out as 
outlined above.  
No difference in ICAM-1 mRNA levels was observed after exposure of the cells to 
stainless steel welding fume (figure 2).  
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Figure 2: mRNA expression of ICAM-1 after exposure to stainless steel welding 
fumes. Exposure caused no change in ICAM-1 mRNA expression in (A) A549s or in 
(B) BEAS-2Bs. Data are from at least two separate experiments and are expressed 
as means of at least 2 samples per experiment. For each sample, mRNA from three 
separate wells was pooled for analysis. RT-PCR reactions were carried out in 
triplicate. Data are compared by unpaired t tests. 
5.2.2 Exposure to welding fumes increases rhinoviral infectivity of A549s and 
BEAS-2Bs 
Previous data showed that mild steel exposure increases susceptibility of lower 
airway epithelial cells to rhinoviral infection by causing an upregulation of the 
rhinoviral entry receptor, ICAM-1. However, no such upregulation was observed 
after exposure of the cells to stainless steel WF. Hence, it was important to study 
the effect of exposure of the cells to WF on rhinoviral infection of lower airway 
epithelial cells.  
A549 and BEAS-2B cells were exposed to the pre-stated doses of WF and then 
infected with a rhinovirus, RV-16, at an MOI of 1. The amount of rhinoviral mRNA 
present in the cells was measured using quantitative real-time PCR. The data were 
normalised to the housekeeping gene and analysed using the ΔΔCt method. UV 
 106 
 
inactivated virus and media in which the virus was grown but from which the virions 
were filtered out were used as controls for viral entry into the cells. 
Exposure of A549s and BEAS-2Bs to mild steel and stainless steel welding fumes 
causes significantly increased rhinoviral infection of these cells (figure 3). A 2-fold 
increase in the amount of viral mRNA seen in A549 cells was seen after exposure to 
mild steel welding fume. In BEAS-2Bs a 3-fold increase was seen. However in both 
A549s and BEAS-2Bs exposed to stainless steel welding fumes a 4-fold increase in 
the amount of viral mRNA was seen.  
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Figure 3: Exposure of lower airway epithelial cells to welding fume following 
rhinoviral infection in order to assess viral infectivity of these cells. A significant 
increase in the amount of viral RNA present in (A) A549 cells exposed to mild steel 
WF (*p<0.05), (B) BEAS-2B cells exposed to mild steel WF (*p<0.05) cells, (C) 
A549 cells exposed to stainless steel WF (**p<0.01) and (D) BEAS-2B cells 
exposed to stainless steel WF (**p<0.01). Data are from at least two separate 
experiments. In each experiment mRNA from 3 samples per condition was 
analysed. Data are expressed as means and are compared using unpaired t tests.  
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5.2.3 Exposure to welding fumes increases susceptibility of rhinovirus 
infected A549s and BEAS-2Bs to bacterial adhesion and invasion 
A549 and BEAS-2B cells were exposed to WF and then infected with RV-16. 
Secondary pneumococcal infection was then assessed as described in the methods 
chapter.  
Exposure of A549s and BEAS-2Bs to welding fume followed by infection with RV-16 
caused a significant increase in pneumococcal adhesion to and invasion of these 
cells (figure 4). In all experiments a significant increase in pneumococcal adhesion 
and invasion was seen in virus infected cells compared to the control and in welding 
fume exposed cells compared to the control. 
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Figure 4: Exposure of lower airway epithelial cells to welding fume followed by viral 
infection, in order to assess secondary pneumococcal infection. A significant 
increase in secondary bacterial infection, compared to either cells only infected with 
virus or only exposed to WF, was seen in (A) A549s exposed to mild steel WF, (B) 
BEAS-2Bs exposed to mild steel WF, (C) A549s exposed to stainless steel WF and 
(D) BEAS-2Bs exposed to stainless steel WF. Data are from at least 3 separate 
experiments. Each data point represents one experiment and is the mean of data 
from at least 3 separate wells. Data are compared using 1 way ANOVA followed by 
Bonferroni’s multiple comparison tests. 
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In order to assess the effect of chronic exposure to welding fume in a similar system 
the cells were exposed to each type of WF at a concentration of 10µg/ml overnight. 
This dose was chosen because it was the highest dose which the cells could be 
exposed to overnight without a loss in cell adherence to the tissue culture plates or 
changes in cell morphology being observed.  
Exposure of A549 and BEAS-2B cells to a low dose of welding fume overnight, 
followed by infection with RV-16 also caused a significant increase in pneumococcal 
adhesion and invasion (figure 5). Overnight exposure of A549 cells to both mild 
steel and stainless steel WF caused a significant increase in pneumococcal 
adhesion and invasion of these cells (**p<0.01, figure 5). In BEAS-2B cells, 
exposure to mild steel WF caused a 1.8 fold increase in pneumococcal adhesion 
and invasion (figure 5B) but this was not statistically significant. However, exposure 
to stainless steel WF caused a significant increase in pneumococcal adhesion and 
invasion in these cells (**p<0.01, figure 5D). In all experiments a significant increase 
in bacterial infection was seen in virus infected cells compared to the control. 
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Figure 5: Exposure of lower airway epithelial cells to low doses of welding fume 
overnight followed by viral infection, in order to assess secondary pneumococcal 
infection. A significant increase in secondary bacterial infection compared to either 
cells only infected with virus or only exposed to WF, was seen in (A) A549s exposed 
to mild steel WF and infected with rhinovirus, and (B) A549s exposed to stainless 
steel WF and infected with rhinovirus. In (C) BEAS-2Bs exposed to mild steel WF, 
no difference in CFU/ml was seen in cells exposed to mild steel WF and infected 
with virus compared to those only infected with virus. However, a significant 
increase in secondary bacterial infection was seen when cells exposed to mild steel 
WF and infected with virus were compared to those only exposed to mild steel WF 
(**p<0.01). In (D) BEAS-2Bs exposed to stainless steel WF and infected with RV-
16, a significant increase in bacterial infection compared to either cells only infected 
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with virus or only exposed to WF was seen. Data are from at least 3 separate 
experiments. Each data point represents one experiment and is the mean of data 
from at least 3 separate wells. Data are compared using 1 way ANOVA followed by 
Bonferroni’s multiple comparison tests. 
5.2.4 Viral- and WF+viral-stimulated increased pneumococcal adhesion and 
invasion of A549 and BEAS-2B cells is PAFR-dependent 
Previous data has shown that rhinoviral infection of lower airway epithelial cells and 
exposure to WF followed by rhinoviral infection increases susceptibility of these 
cells to secondary pneumococcal infections. This led to the question: is this 
increased susceptibility PAFR-dependent?  
In order to assess this the cells were exposed to welding fumes, infected with RV-16 
and pre-treated with the PAFR blocker, CV-3988, before pneumococcal infection. 
Since similar effects of both types of WF was seen on virus-induced pneumococcal 
adhesion and invasion in both cell types, only mild steel WF was used to confirm the 
role of PAFR using CV-3988. 
CV-3988 attenuated both rhinovirus induced and WF+rhinovirus induced 
pneumococcal invasion and adhesion in both cell types (figure 6). In all experiments 
rhinoviral infection alone and exposure to WF followed by rhinoviral infection caused 
a significant increase in secondary pneumococcal infection compared to the 
controls. However, in A549 cells no difference in pneumococcal adhesion and 
invasion was seen between cells infected with rhinovirus only and cells exposed to 
WF followed by rhinovirus infection (figure 6A). In BEAS-2B cells there was a 1.4 
fold difference in secondary pneumococcal infection between these two conditions, 
which was not statistically significant (figure 6B). This was not consistent with data 
presented in figure 4 of this chapter.  
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Figure 6: Use of the PAFR blocker, CV-3988, to assess the role of PAFR in 
rhinoviral- and WF+rhinoviral-induced pneumococcal adhesion and invasion. RV-
16- and mild steel WF+RV-16-stimulated secondary pneumococcal infection was 
attenuated by CV-3988 in (A) A549, and (B) BEAS-2B cells. Data are from 3 
separate experiments. Each data point represents one experiment and is the mean 
of data from 3 wells.  Data are compared using Bonferroni’s multiple comparison 
tests. 
5.2.5 Treatment with iota carrageenan attenuates rhinovirus-induced 
secondary pneumococcal infections in lower airway epithelial cells 
With the current lack of treatments for rhinovirus infections it was of interest to 
investigate the anti-rhinoviral effects of a recent compound of interest, iota 
carrageenan. Specifically, it was of interest to investigate whether iota carrageenan 
affects rhinovirus-induced secondary pneumococcal infections.  
Alveolar and bronchial epithelial cells were treated with 25µg/ml iota carrageenan 
during rhinovirus infection. After removal of the virus the iota carrageenan was 
added back to the cells and left overnight. The cells were then infected with S. 
pneumoniae at an MOI of 100. Adherent and internalised bacteria were then 
assessed.  
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In both A549s (***p<0.001, figure 7A) and BEAS-2BS (***p<0.001, figure 7B) IC 
attenuated rhinovirus-induced pneumococcal infections. The rhinovirus infection 
induced a 2 fold increase in pneumococcal infection in both A549s and BEAS-2Bs 
(***p<0.001, figure 7). 
 
Figure 7: Effect of IC on rhinovirus-induced pneumococcal infections in (A) A549 
cells and (B) BEAS-2B cells. In both cell types rhinovirus infection significantly 
increased pneumococcal infection which was reduced to control levels by treatment 
with IC. The data are from at least 2 experiments. Each data point represents a 
single replicate. The data are compared using 1 way ANOVA followed by 
Bonferroni’s multiple comparison test. 
5.3 Conclusions 
Welders are more susceptible to viral pneumonia compared to the general 
population143. Hence, one of the aims of this study was to assess the effect of 
exposure to welding fumes on the susceptibility of lower airway epithelial cells to 
rhinoviral infection. ICAM-1 is a known receptor used by rhinoviruses for entry into 
lower airway epithelial cells. Surface and mRNA expression has been shown to 
increase after exposure of A549 cells to RV-16 in a virus dose dependent manner 
with expression peaking at MOI 1. RV-16 infection (MOI 1) has also been shown to 
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increase ICAM-1 surface expression in primary bronchial cells33. In this investigation 
ICAM-1 mRNA was analysed. In a preliminary experiment conducted to test the 
viability of the virus it was observed that constitutive expression of ICAM-1 was low 
relative to expression after exposure of both A549 and BEAS-2B cells to rhinovirus. 
This is consistent with what is reported in the literature33. In order to assess whether 
exposure to welding fume increases susceptibility of lower airway epithelial cells to 
infection by RV-16, ICAM-1 mRNA was compared in cells exposed or unexposed to 
welding fumes. In both cell types a significant increase in ICAM-1 mRNA was 
observed after exposure to mild steel welding fume. It has previously been reported 
that exposure of rat lung epithelial cells to diesel exhaust particles causes increased 
ICAM-1 mRNA expression147. However, this is the first time that increased ICAM-1 
mRNA expression has been observed in human respiratory epithelial cells exposed 
to mild steel WF. ICAM-1 mRNA expression was not affected by exposure to 
stainless steel welding fume.  
In order to further address the question of susceptibility to infection by rhinovirus, 
viral infectivity of the cells was assessed. This was done by measuring the amount 
of viral mRNA present in the cells after infection. The data showed that lower airway 
epithelial cells exposed to both mild steel and stainless steel welding fume and then 
infected with RV-16 contained approximately 2-4 times more viral RNA compared to 
those unexposed to WF and also infected with RV-16. This suggests that while 
exposure to stainless steel WF increases susceptibility to rhinoviral infection, this 
increased susceptibility may not be ICAM-1 dependent as is the case with exposure 
to mild steel welding fume. Members of the low density lipoprotein receptor (LDLR) 
family have also been implicated as entry receptors for rhinoviruses33. Further work 
is required to better understand the molecular mechanisms involved in stainless 
steel WF exposure-conferred increased susceptibility of lower airway epithelial cells 
to rhinoviral infection.  
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Since welders are more susceptible to viral and pneumococcal pneumonia and 
secondary pneumococcal infections can lead to fatalities in patients with viral 
pneumonia it was important to assess the effect of exposure to welding fumes and 
viral/bacterial infections in lower airway epithelial cells. In order to do this both acute 
and chronic exposure to welding fumes was modelled in vitro. Acute, short-term 
exposure to WF, as referred to in chapter 3, followed by rhinoviral infection caused 
increased pneumococcal adhesion and invasion of lower airway epithelial cells. 
Viral stimulation of pneumococcal adhesion and invasion was similar to WF 
stimulation of pneumococcal infection in these experiments.  
Chronic exposure conditions were modelled using a 24hour stimulation of the cells 
with WF. A dose of 10µg/ml was used as it was the highest dose that was tolerated 
by the cells for 24 hours. Under these exposure conditions pneumococcal adhesion 
and invasion was stimulated above control levels in A549s for both types of WF but 
in BEAS-2Bs for only stainless steel WF.  No additive effect of WF stimulation and 
rhinoviral infection was seen in BEAS-2B cells exposed to mild steel WF. These 
data suggest that chronic exposure to higher doses of mild steel WF may be 
required for increased pneumococcal infection of these cells. While chronic 
exposure to higher doses is difficult to model in this system due to issues with cell 
viability mentioned previously, it is not unrealistic to expect under physiological 
conditions. Hence, for further studies chronic exposure may be better modelled 
using an in vivo system.  An additive effect of WF stimulation and rhinoviral infection 
on pneumococcal adhesion and invasion was observed in both A549 cells exposed 
to both types of WF and in BEAS-2B cells exposed to stainless steel WF.  
Data presented in chapter 3 showed a role for PAFR in WF-stimulated 
pneumococcal adhesion and invasion of lower airway epithelial cells. Additionally, it 
has been previously shown that human pharyngeal and tracheal epithelial cells 
either exposed to poly I:C or infected with human rhinovirus have increased PAFR 
 117 
 
expression and are more susceptible to pneumococcal adhesion. Increased 
pneumococcal adhesion was attenuated by PAFR blockers in both these 
studies30,43. Hence, it was important to assess whether PAFR has a role in 
rhinovirus-stimulated pneumococcal infection of alveolar and bronchial cells, which 
are putative sites of pneumococcal infection. The PAFR blocker, CV-3988, 
attenuated both RV-16-stimulated pneumococcal infection and WF+RV-16-
stimulated pneumococcal infection in A549 and BEAS-2B cells. This further 
strengthens the case presented in chapter 3 for PAFR as an anti-infective target in 
welders. In these experiments the CFU counts observed after exposure of the cells 
to mild steel WF followed by rhinoviral infection were approximately 2 fold lower 
compared to those presented in figure 4 of this chapter. Further, no additive effect of 
RV-16 and WF was observed on pneumococcal adhesion and invasion in A549 
cells. This may be due to reduced virulence of the pneumococcal stocks, caused by 
long term storage. Similar effects on pneumococcal virulence have been previously 
observed in the lab.  
In this study the effect of IC on rhinovirus-induced pneumococcal infection was also 
assessed. IC has recently been examined for anti-rhinoviral activity39–41. However, 
to date it is unknown whether this anti-rhinoviral activity extends to an effect on 
secondary bacterial infections. Hence, this study provides first evidence that IC 
attenuates secondary pneumococcal infections after a rhinovirus infection. Currently 
there are no effective preventions or treatments for rhinovirus infections. Hence, the 
known anti-rhinoviral activity of IC, its safety profile and the evidence presented in 
this chapter for its protective effect on secondary pneumococcal infections make it a 
good candidate for further investigation as an anti-rhinoviral therapy. However, 
further work needs to be done to better understand the mechanisms by which IC 
exerts its anti-rhinoviral effects. 
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Chapter 6: PAFR expression and 
localisation in the human lung 
after exposure to airborne 
particulate matter 
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6.1 Introduction and aims 
PAFR is a known entry receptor for S. pneumoniae8. The data presented in 
chapters 3 and 4 of this thesis and previous work in our lab have shown that 
exposure to WF and cigarette smoke extract (CSE) causes a PAFR-dependent 
increase in pneumococcal adhesion and invasion of lower airway epithelial cells in 
vitro. Additionally, higher PAFR expression has been shown in the bronchial 
epithelium of smokers compared to healthy controls123. Chronic obstructive 
pulmonary disorder (COPD) is a chronic respiratory condition of which one of the 
causes is smoking60. Hence PAFR expression and localisation in these subjects 
was also of interest. 
COPD patients are highly susceptible to infections. Rhinoviruses have been shown 
to be associated with COPD exacerbations and patients with a rhinovirus infection 
and secondary bacterial infections such as pneumococcal infections have increased 
airway inflammation and poorer clinical outcomes60. Data presented in chapter 5 
showed that PAFR mediates rhinovirus induced pneumococcal infection of lower 
airway epithelial cells. Hence, PAFR expression and localisation in human subjects 
experimentally infected with rhinovirus was of interest to study.  
Endobronchial biopsies were obtained from healthy non-smokers, smokers without 
airway obstruction, and smokers with COPD, before and after infection with 
rhinovirus RV-16158.  
The aims of this study were to assess the localisation of PAFR protein in human 
lung samples from a welder compared to a healthy control. Additionally, PAFR 
mRNA expression and protein expression and localisation were also assessed in 
the endobronchial biopsies of smokers and smokers with COPD from an 
experimental rhinovirus infection model. 
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6.2 Results  
6.2.1 PAFR expression and localisation in the lungs of welders 
Sophie Lanone (INSERM, France) kindly provided paraffin embedded lung biopsy 
section slides from a non-smoking control and a non-smoking welder for 
immunohistochemical analysis. While the functional relevance of PAFR expression 
to vulnerability to pneumococcal infections has been presented in chapter 3, these 
slides allowed the characterisation of PAFR expression and distribution in a 
welder’s lung. Hence, although the number of samples available made it impossible 
to carry out statistical analyses they provide some valuable insights. 
Image analysis of these slides was conducted as described in the methods chapter 
of this thesis. A mouse anti-human PAFR antibody was used to stain the tissue 
(brown stain). The nuclei were visualised using 3, 3’ diamino benzidine (DAB) (blue 
stain).  A qualitative assessment of PAFR positivity was carried out. More PAFR 
positive bronchial epithelial cells, indicated by the black arrows, were seen in the 
welder sample (figure 1B) compared to the non-smoking control (figure 1A). 
Additionally, large amounts of particulate matter deposits were observed in the 
welder sample as indicated by the white arrows. Such deposits were absent in the 
control sample.  
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Figure 1A: PAFR staining seen in the non-smoking control. Staining is seen on the 
bronchial epithelium, which showed normal pathology, as indicated by the black 
arrow. No particulate matter deposits were seen in this sample. 
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Figure 1B: PAFR staining seen in the non-smoking welder sample. Staining is seen 
on the bronchial epithelium, which showed normal pathology, as indicated by the 
black arrow. The white arrows indicate particulate matter deposits seen in the 
sample. 
6.2.2 Human PAFR expression in an experimental model of rhinovirus 
infection in smokers and smokers with COPD 
RNA extractions, cDNA synthesis and RT-PCR reactions were carried out by a 
technician in the laboratory, Lee Koh. Experimental design and data analysis were 
carried out by the author of this thesis. 
6.2.3 Smokers with COPD have higher baseline levels of PAFR mRNA 
compared to smokers without COPD and non-smokers 
The subject demographics for the study are included in table 1. There was no 
significant difference in age or body mass index between the three groups. 
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Table 1. Subject Demographics and endobronchial PAFR mRNA expression 
 Non-smokers Smokers COPD 
N 18 16 14 
Age (yr) 59.2 ± 1.6 54.3 ± 1.8 59.6 ± 2.2 
Body mass index 
(kg/m2) 
25.2 ± 1.0 27.1 ± 0.9 25.7 ± 1.1 
Females (n) 9 7 5 
Smoking pack years 
(n) 
0 33.25 ± 2.21 39.35 ± 2.24 
FEV1 (% predicted) 112.3 ± 4.4 102.9 ± 3.4 64 ± 3.4 
FVC (% predicted) 124.4 ± 4.8 117.5 ± 3.0 95.0 ± 3.5 
FEV1/FVC  78  ± 1.0 75 ± 1.0 62 ± 1.7 
 
Table 1: Subject demographics for the study. Data are summarised as mean ± 
standard error of mean. FEV1: forced expiratory volume in 1 s, FVC: forced vital 
capacity 
 
Baseline PAFR mRNA expression levels were compared between non-smokers, 
smokers and smokers with COPD. Since exposure of lower airway epithelial cells to 
CSE caused a PAFR-dependent increase in pneumococcal adhesion and invasion 
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of these cells it was hypothesised that smokers and smokers with COPD have 
higher baseline expression levels of PAFR. 
Baseline PAFR mRNA expression levels were assessed in 18 non-smokers, 16 
smokers and 14 smokers with COPD using TaqMan primers and probes. Relative 
expression levels were measured and normalised to the housekeeping gene, 
GAPDH.  
Baseline expression levels in smokers and smokers with COPD were significantly 
higher compared to non-smokers (figure 2). No difference in levels was seen 
between smokers and smokers with COPD.  
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Figure 2: Baseline PAFR mRNA expression in non-smokers, smokers and smokers 
with COPD. Real time PCR reactions were carried out in triplicate. Significantly 
higher levels were seen in smokers and smokers with COPD compared to the non-
smoking controls (*p<0.05). Data are compared using 1 way ANOVA followed by 
Dunnett’s multiple comparison test.  
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6.2.4 Rhinovirus infection does not increase PAFR mRNA expression in the 
human lung 
Based on the data presented in chapter 5 which showed that rhinoviral infection of 
lower airway epithelial cells causes PAFR-dependent increased pneumococcal 
infection it was hypothesised that rhinoviral infection upregulates PAFR expression. 
To assess this, baseline PAFR mRNA levels were compared with 7 day post-
rhinoviral infection levels. Paired samples were available from 9 non-smokers, 8 
smokers and 7 smokers with COPD. The day 7 samples were analysed and 
processed similarly to the baseline samples, as outlined above.  
Paired analyses showed no significant difference in PAFR mRNA expression before 
and after rhinovirus infection in non-smokers with a trend towards higher PAFR 
expression after infection (p=0.09) (figure 3A). There was no difference in 
expression, before and after infection, in either smokers or smokers with COPD 
(figure 3B, 3C).  
 
Figure 3: Paired changes in PAFR expression before and after rhinovirus infection 
in (A) non-smokers, (B) smokers and (C) smokers with COPD. A trend towards 
higher mRNA expression of PAFR was seen in non-smokers after rhinoviral 
infection. No difference in PAFR mRNA expression was seen in either smokers or 
smokers with COPD before and after rhinovirus infection. Data are compared using 
paired t tests. 
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6.2.5 PAFR mRNA expression in non-smokers, smokers and smokers with 
COPD 7 days after rhinovirus infection. 
Although PAFR mRNA expression did not change within each group of subjects 
after rhinovirus infection, it was of interest to compare post-infection PAFR mRNA 
levels between groups. This was done to assess whether smokers with COPD are 
at a higher risk of PAFR-mediated pneumococcal infection compared to non-
smokers after rhinovirus infection.  
No difference in post-rhinoviral infection PAFR mRNA levels was seen between 
non-smokers and smokers with COPD though there was a trend towards higher 
levels in smokers with COPD (p=0.08). Further, a trend towards higher levels in 
smokers with COPD was seen compared to smokers without reduced lung function 
(p=0.09). 
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Figure 4: Comparison of post-rhinoviral infection PAFR mRNA levels in non-
smokers, smokers and smokers with COPD. A trend towards higher expression 
levels was seen in smokers with COPD compared to non-smokers and smokers 
with normal lung function. Data were compared using t tests. 
6.2.6 PAFR positive cells are predominantly located at the bronchial air-tissue 
interface  
Paraffin embedded baseline bronchial tissue was used to study the localisation of 
PAFR protein expression using immunohistochemical methods. A mouse anti-
human PAFR antibody was used to stain the tissue (brown stain). The nuclei were 
visualised using 3,3' diamino benzidine (DAB) (blue stain).  
Baseline tissue samples were available from 7 non-smokers, 7 smokers and 7 
smokers with COPD. Due to the limited availability of samples it was not possible to 
quantify and compare cell specific PAFR expression. However, it was possible to 
carry out a qualitative analysis of the samples available.  
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Platelet-activating factor receptor immunostaining showed positive cells in the 
airway epithelium of all 21 subjects. Representative images of the samples available 
for analysis are shown below (figure 5). PAFR positive goblet cells were found in 
both smokers and smokers with COPD (figure 5C). PAFR positive bronchial 
submucosal gland cells, as seen in figure 5D, were also found in all 10 subjects 
where bronchial glands were sampled by the biopsy (controls n=4, smokers n=3, 
and smokers with COPD n=3). PAFR positivity of other cells, such as smooth 
muscle cells was minimal to absent (figure 5A). Areas of squamous metaplasia 
were found only in smokers and smokers with COPD. PAFR immunostaining of 
squamous metaplasia was lower than areas of more normal bronchial epithelium 
(figure 5B). 
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Figure 5A: Example of PAFR staining seen in non-smokers. Staining is seen on the 
airway epithelium, which showed normal pathology, as indicated by the black arrow. 
The white arrow indicates smooth muscle tissue in which staining was minimal in 
this sample. The other non-epithelial positive staining seen in the image is a 
bronchial gland. 
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Figure 5B: Example of PAFR staining in smokers. PAFR staining was higher on the 
normal epithelium (N) compared to the squamous metaplastic epithelium (SM).  
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Figure 5C: Example of PAFR staining in smokers with COPD. PAFR staining was 
predominantly in the epithelium as indicated by the black arrow. Goblet cell rich 
epithelium as seen in this example was observed in both smokers and smokers with 
COPD.  
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Figure 5D: Example of PAFR staining in the bronchial glands. PAFR positivity in the 
bronchial submucosal glands, as indicated by the black arrow, was seen in all 
subjects in whom the glands were sampled by the biopsy. 
 133 
 
6.3 Conclusions  
Qualitative analysis of the non-smoking control and welder lung samples available 
showed that the welder sample had more PAFR positive bronchial epithelial cells. 
These cells are situated at the air-tissue interface and hence are exposed to airway 
bacteria. To date this is the first time that PAFR expression and localisation has 
been assessed in a welder’s lung. Taken with the functional evidence for a role of 
PAFR in WF-mediated lower airway vulnerability to pneumococcal infection 
presented in chapter 3, this observation may have important clinical implications. 
However, a well powered study in welders needs to be conducted in order to 
confirm this observation.   
Cigarette smoking causes chronic respiratory diseases such as COPD. COPD 
patients are highly susceptible to respiratory infections. Rhinoviruses have been 
shown to be associated with COPD exacerbations and secondary bacterial 
infections are a common occurrence60.  Exposure of lower airway epithelial cells to 
cigarette smoke extract has been shown to cause a PAFR-dependent increase in 
pneumococcal invasion and adhesion. Additionally, a higher proportion of bronchial 
epithelial cells have been shown to express PAFR in smokers compared to healthy 
controls123. Hence, it was hypothesised that baseline PAFR expression would be 
higher in smokers and smokers with COPD, compared to non-smokers. Indeed in 
this study it was found that smokers and smokers with COPD have higher PAFR 
mRNA levels compared to non-smokers. However, there was no significant 
difference in baseline PAFR expression between smokers and smokers with COPD. 
This suggests that smoking per se increases PAFR-dependent susceptibility to 
pneumococcal infection and that there is no association between reduced lung 
function seen in COPD patients and PAFR mRNA expression.  
Immunohistochemical analyses of baseline PAFR expression in paraffin embedded 
bronchial biopsy samples showed that PAFR is predominantly expressed in the 
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airway epithelium and bronchial submucosal glands.  Both these areas of tissue are 
exposed to air. This suggests that the changes in PAFR mRNA expression 
observed can be mapped to areas that are exposed to airway bacteria. This, taken 
with the in vitro evidence that exposure to CSE increases susceptibility of bronchial 
epithelial cells to pneumococcal adherence, supports the hypothesis that PAFR has 
a role in increased susceptibility of smokers and smokers with COPD to 
pneumococcal infections. However, the role of PAFR in susceptibility to 
pneumococcal infections in COPD patients is yet to be elucidated. 
Areas of squamous metaplasia and goblet cell rich epithelium were seen in smokers 
and smokers with COPD. Squamous metaplasia (SM) is a type of epithelial cell 
remodelling associated with chronic irritation and goblet cell hyperplasia is a 
common feature of COPD159. These observations are consistent with literature that 
suggests a role of PAFR in driving goblet cell hyperplasia in a guinea pig model of 
chronic exposure to cigarette smoke116. It was also observed that PAFR staining 
was lower in squamous metaplastic areas of the epithelium. The low quality of the 
samples available for immunohistochemistry analysis and the differential staining 
patterns seen in the different types of epithelium made it difficult to quantify changes 
in PAFR expression. Hence, only qualitative observations were made about the 21 
samples available. However, taken with the evidence that PAFR is an entry receptor 
for pneumococci, the pattern of staining suggests that airway remodelling towards 
an SM phenotype may confer protection against pneumococcal infections. Further 
work is required to explore the implications of this observation.  
Data presented in chapter 5 showed that rhinoviral infection of lower airway 
epithelial cells increased pneumococcal adhesion and invasion in a PAFR-
dependent manner. Additionally, it has previously been shown that rhinovirus 
infection upregulates PAFR expression in respiratory epithelial cells and 
pneumococcal adhesion to these cells30,160. Contrary to these findings, in this study 
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PAFR mRNA expression levels did not change after rhinovirus infection in non-
smokers, smokers or smokers with COPD. Since baseline PAFR mRNA expression 
was higher in smokers and smokers with COPD, compared with non-smokers, it is 
hypothesised that baseline PAFR expression is at maximum possible levels and 
cannot be further upregulated by additional stimulation. Due to the lack of post-
rhinovirus infection samples for immunohistochemical analysis it was not possible to 
compare PAFR protein expression before and after rhinoviral infection. Hence, it 
was not possible to test this hypothesis in this study. Further, the samples may have 
provided a better insight into paired changes pre- and post-rhinoviral infection in 
non-smokers. The paired changes in PAFR mRNA expression were not significant 
but there was a trend towards higher expression after rhinoviral infection.  Further 
work is required to better understand how rhinovirus infection affects PAFR 
expression, in vivo, in cells exposed to airway bacteria. 
Post-rhinoviral infection PAFR mRNA levels were compared between non-smokers, 
smokers and smokers with COPD. No significant differences between the groups 
were observed. However, there were trends towards higher expression levels in 
smokers with COPD compared with non-smokers and smokers with normal lung 
function. Again, the study was limited by the lack of post-rhinoviral samples for 
immunohistochemical analysis. However, it was found that 6 out of the 7 smokers 
with COPD from whom samples were available developed secondary infections by 
the ChoP-expressing bacteria, S. pneumoniae and H. influenzae. ChoP is a 
component of the bacterial cell wall which interacts with PAFR to facilitate bacterial 
invasion of host cells. No rhinovirus infected non-smokers or smokers with normal 
lung function developed secondary infection by ChoP-expressing bacteria.  
A major limitation of this study is statistical power. This is because the samples 
analysed in this study were mined from another larger study from which a proportion 
of samples were unavailable60. This study provides first insight into the expression 
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of PAFR in smokers with COPD. PAFR expression is elevated in smokers with 
COPD in cells exposed to airway bacteria at the air-tissue interface, compared with 
non-smokers. Further, in spite of a possible increase in PAFR expression in non-
smokers after rhinoviral infection PAFR expression may remain elevated in smokers 
with COPD compared with non-smokers. This has significant clinical implications 
when taken with the observation that approximately 85% of smokers with COPD in 
this study developed infections by ChoP-expressing bacteria secondary to rhinoviral 
infection. Thus, data presented in this chapter further strengthens the case for 
therapeutic blocking of PAFR in smokers with COPD. 
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Chapter 7: Discussion 
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7.1 Background summary 
Pneumonia is a leading cause of death worldwide and the main bacterial causative 
agent of pneumonia is S. pneumoniae. S. pneumoniae is a Gram positive bacterium 
which is asymptomatically carried in the nose by a large proportion of the 
population3. The pneumococcal surface contains ChoP which is also part of the 
human platelet activating factor (PAF). It has been shown than the pneumococcus 
mimics PAF and binds its receptor, PAFR, thus co-opting human PAFR for entry 
into host cells8.  
Viral infections, such as rhinovirus infections, exacerbate pneumonia by increasing 
susceptibility to secondary bacterial infections. The human rhinovirus has been 
shown to co-opt host receptors such as ICAM-1 and low density lipoprotein (LDL) 
for entry into host cells32,33.  
Exposure to airborne particulate toxins, such as PM10 and cigarette smoke, has 
been shown to increase vulnerability to pneumococcal infection86,123. One focus of 
this study was occupational exposure to particulate matter in welders. Welders have 
been shown to be more susceptible to pneumonia in several epidemiological 
studies4,142,143. Cigarette smoking is highly prevalent amongst this population of 
workers and may further increase vulnerability as well as vulnerability to invasive 
disease144. Little is known about the molecular mechanisms involved. The current 
Health and Safety Executive guidance in the UK is that there is an association 
between exposure to welding fume and risk of developing pneumonia but that 
employers should prioritise welding fume exposure control measures over offering 
employees the pneumococcal vaccine161. 
The second focus of this thesis was smokers with COPD. Chronic smoking or 
exposure to indoor air pollution, such as biomass or wood smoke, may lead to 
chronic respiratory conditions and reduced lung function61–63. COPD sufferers are 
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highly susceptible to viral and bacterial infections which exacerbate their condition. 
Rhinoviruses and S. pneumoniae are two of the commonly isolated pathogens in 
COPD exacerbations but the mechanisms that increase susceptibility of these 
patients to infections are poorly understood.  
7.2 Questions addressed 
In the context outlined above this thesis aimed to address the following questions: 
1. Does exposure to welding fumes cause a PAFR- and oxidative stress-
dependent increase in susceptibility to pneumococcal pneumonia? 
2. Does exposure to welding fumes cause an increase in susceptibility to 
rhinoviral infection and to secondary bacterial infections? 
3. Do COPD patients, who are highly susceptible to both viral and bacterial 
infections, have increased PAFR expression in the lung epithelium? 
7.2.1 Question 1: Exposure to WF and susceptibility to pneumococcal 
pneumonia: role of PAFR and oxidative stress 
Epidemiological studies have shown that welders of working age are more 
susceptible to pneumococcal infections but that this effect is reversible. This 
suggests that welding per se may increase susceptibility to pneumococcal 
infection4,142,143. Smoking is a major confounder in these studies which also suggest 
that smoking may increase susceptibility of welders to invasive pneumococcal 
disease144. To date no biological plausibility of increased vulnerability of welders to 
pneumococcal infection has been established and little is known about the 
molecular mechanisms.  
PAFR is a known entry receptor for the pneumococcus in host cells. It has been 
shown that a mucolytic drug, S-CMC, which attenuates pneumococcal adherence to 
lower airway epithelial cells, also attenuates PAFR protein and mRNA expression in 
 140 
 
these cells15. Additionally, work on the effect of other airborne toxins such as PM10 
and CSE on vulnerability of lower airway epithelial cells to pneumococcal infection 
has shown that a PAFR blocker attenuates this vulnerability. PAFR expression has 
also been shown to be higher in the lungs of mice exposed to cigarette smoke and 
in the lungs of smokers123. This evidence suggests that PAFR may be a common 
receptor involved in particulate matter-stimulated vulnerability to pneumococcal 
infection in airway epithelial cells. Indeed the data in this thesis supports that idea 
and is the first evidence of a role of PAFR in WF-stimulated vulnerability of airway 
cells to pneumococcal infection.  
Given that S. pneumoniae is commonly carried in the nasal cavity, it is of 
significance that exposure to WF increases susceptibility of nasal epithelial cells to 
pneumococcal infection. This finding raises important questions such as can 
pneumococci translocate across the nasal epithelial barrier into the blood stream? 
Does infection of the nasal epithelium lead to inhalation of the bacteria into the 
lower airway? 
Like PM10 and CSE, both types of WF used in this study i.e mild steel and stainless 
steel WF, are complex chemical mixtures. The two elements found in all three types 
of WF used in this thesis were iron and manganese. Chromium and potassium were 
contained in at least two of the three types of WF. Hence, the next steps for this 
work would be to dissect out the effects of the various metal components in this 
system in order to better understand differential effects of the different types of WF 
used.   
A specific PAFR blocker was used in the in vitro functional studies. Additionally, 
PAFR protein expression was higher in lower airway epithelial cells after WF 
exposure. PAFR mRNA expression was also upregulated in the lungs of mice 
exposed to WF by inhalation and by intranasal inhalation. Further, higher PAFR 
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protein expression was seen in the lungs of a welder compared to a non-welder. 
While this evidence strongly suggests a role for PAFR in WF-stimulated vulnerability 
to pneumococcal infection in vitro and in vivo, the study has some limitations. First, 
although CV-3988 is a specific PAFR antagonist it is a synthetic agent and may 
have other, yet unknown, effects on cells. PAFR mRNA studies in cell lines proved 
inconclusive. It may have been useful to study the kinetics of PAFR expression in 
the cell lines to understand why this was the case. However, due to the availability 
of an animal model and some human tissue to confirm the PAFR expression 
findings PAFR mRNA studies in the cell lines were abandoned. It would be of 
interest to work with or develop a PAFR knockout mouse but time and financial 
consideration did not allow for this for this thesis162. Finally, the human lung samples 
available for PAFR protein analysis were mainly from smokers and ex-smokers. 
This confounded the analysis and so it was only possible to assess the effect of 
welding per se on PAFR expression in the lungs of one welder and one non-welder.  
Similar to PAFR expression, oxidative stress has also been shown to be increased 
by exposure to inhalable toxins. Bronchial epithelial cells exposed to PM have 
increased ROS, IL-8 and IL-1β release. These increased levels have been shown to 
be attenuated by NAC which is an anti-oxidant68,69. NAC has also been shown to 
attenuate lower airway cell injury and pneumococcal adhesion to these cells caused 
by exposure to CSE123. The literature reports increased free radical, ROS and NO 
production after exposure to WF139,141,155. The data in this thesis, which show a role 
for the anti-oxidant, NAC, in attenuating WF-stimulated pneumococcal adhesion, 
provide functional relevance for oxidative stress in WF associated pneumococcal 
infections. Although ROS release was not measured in this system the data 
highlight the possibility of the involvement of other related mechanisms. It would be 
of interest to investigate the relationship between oxidative stress and PAFR 
expression in lower airway epithelial cells in the context of pneumococcal infections.  
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A mouse model of pneumococcal infection was used to assess whether exposure to 
WF per se increased susceptibility to pneumococcal infection. A major limitation of 
this model was the method of WF delivery. Ethical considerations only made it 
possible to deliver WF using intranasal instillation, which is not physiological. Lung 
samples from a study in mice exposed to WF by inhalation were available for PAFR 
mRNA analysis, as discussed above, but not for investigation of vulnerability to 
pneumococcal infection. The intranasal method of WF delivery made it difficult to 
calculate a physiologically relevant dose because to date there have been no 
studies which measure particle deposition in the alveolar and bronchial regions in 
welders. It is currently estimated that welders are exposed to 80mg/m3*years of 
WF132,133. Hence, the dose chosen was one that was tolerated by the mice by 
intranasal instillation under anaesthesia with minimum discomfort and that did not 
cause the BALF to turn brown 24 hours after instillation. A dose of 600µg was the 
highest possible tolerated by a single mouse by intranasal inoculation under 
anaesthesia. The only other mouse study in which the WF was delivered in a similar 
way used a total dose of 400µg/mouse delivered in 100µg instalments over 4 
different days134. In our low dose chronic exposure experiment we delivered a total 
of 600µg/mouse in 100µg instalments over 6 different days. Other studies in rats 
have used a total dose of 2mg/rat139,145,155.  
The mouse studies showed that exposure to WF caused increased pneumococcal 
infection but did not cause invasive pneumococcal disease. Given that invasive 
disease was only seen in some smoking welders in epidemiological studies it may 
be of interest to show biological plausibility in mice exposed to both cigarette smoke 
and WF144. This may help to further dissect out the differences in effects caused by 
WF per se vs. smoking + exposure to WF.  
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7.2.2 Question 2: Exposure to WF and vulnerability to viral infections and 
secondary pneumococcal infections 
There is a body of literature which supports the idea that viral infections predispose 
to secondary bacterial infections30,43–45,51. Of particular interest for this thesis, in the 
context of pneumonia, were the interactions between rhinovirus, which is frequently 
associated with exacerbation of COPD, and the pneumococcus. Since welders are 
more susceptible to pneumonia compared to the general population it was of 
interest to assess whether exposure to WF increases vulnerability to rhinoviral 
infection and subsequently to secondary pneumococcal infection.  
The human rhinovirus co-opts host receptors such as ICAM-1 and LDL for entry into 
host cells33. For this thesis human rhinovirus subtype A, serotype 16 was used. The 
entry receptor for RV-16 is known to be ICAM-1. ICAM-1 is known to be upregulated 
by viral infection in airway epithelial cells33. Exposure of lower airway epithelial cells 
to mild steel WF, upregulated ICAM-1 expression in both cell lines used. This 
suggests that exposure to mild steel WF increases vulnerability of these cells to 
rhinoviral infection. This was confirmed by assessing the amount of viral mRNA in 
these cells after exposure to mild steel WF. However, with stainless steel WF, 
although increased viral infectivity was seen, the exposure to stainless steel WF did 
not upregulate ICAM-1 expression. Although the functional outputs from using the 
two types of WF were similar the mechanisms involved are not. This suggests that 
ICAM-1 is not the only receptor used by RV-16 to infect host cells and comes back 
to the question of understanding how the components of each type of WF contribute 
to the differential effects seen. This work was not expanded as its main aim was to 
show that exposure to WF increases susceptibility to rhinoviral infection in lower 
airway epithelial cells. However, current ideas for expansion include the use of an 
anti-ICAM-1 agent to test the role of ICAM-1 in WF-stimulated susceptibility to viral 
infection. An anti-ICAM-1 antibody was used to this effect but the large amount of 
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antibody required for the experiments coupled with the inconclusive data caused 
this avenue of enquiry to be put on hold. It is also of interest to study the effect of 
WF exposure on LDL expression in lower airway epithelial cells.  
Rhinoviral infection of WF exposed lower airway epithelial cells increased their 
vulnerability to secondary pneumococcal infections. These data are of some 
significance to strategies to protect welders against pneumonia but have some 
limitations. As mentioned earlier in this chapter S. pneumoniae is carried in the nose 
in a large proportion of the general population3. Similarly rhinoviruses are primarily 
thought to infect the upper airway163. Hence it is of interest to investigate the 
possibility that the pathogens are inhaled into the lower airway from infected nasal 
cells. The development of a cell culture system to model this is currently in 
progress. Another limitation of the study was in the modelling of the exposure to a 
low dose of WF for a longer period of time. With the cell culture system used in this 
thesis it was only possible to model the overnight exposure to a single dose 
(10µg/ml). This was because it was the highest dose tolerated by the cells. It may 
be of more physiological relevance to use a mouse model to study the effect of 
chronic exposure to WF on rhinoviral/pneumococcal infections.  
Given that PAFR has a role in WF-stimulated pneumococcal infection of airway 
epithelial cells it was of interest to assess the role of PAFR in cells co-infected with 
rhinovirus and pneumococci. There is a body of evidence that supports a role for 
PAFR in viral/pneumococcal interactions. Pharyngeal cells exposed to poly I:C were 
more susceptible to pneumococcal infections, which was attenuated by a PAFR 
antagonist43. Tracheal epithelial cells infected with rhinovirus were more susceptible 
to pneumococcal infections which were attenuated by a PAFR antagonist30. 
Additionally, in mice infected with influenza a PAFR antagonist reduced lethality, 
lung injury and neutrophil recruitment48,49. Finally, returning to the idea of a common 
role of PAFR in particulate matter-stimulated effects is a study in mice exposed to 
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diesel exhaust particles that had upregulated PAFR mRNA levels in the lungs147. 
Hence, it is not surprising that CV-3988 attenuated WF- and rhinovirus-stimulated 
pneumococcal infection of lower airway epithelial cells in vitro.   
Currently the field is open for studies to identify novel anti-rhinoviral agents due to 
the lack of reliable preventions or cures. Iota-carrageenan has shown promise in 
randomised control trials in adults and children in which a reduction in nasal viral 
loads has been seen. Additionally, the compound has proved to be safe in children 
down to 6 months of age and is approved for over the counter use39–41. However, 
little is known about the molecular mechanisms of its anti-rhinoviral activity. Due to 
the focus of this thesis on pneumonia it was of importance to assess the effect of 
iota carrageenan on secondary pneumococcal infections in rhinovirus infected lower 
airway epithelial cells. Showing an effect of iota carrageenan on secondary 
pneumococcal infections in rhinovirus infected cells was the first step in its study. 
Future work includes developing a better understanding of how IC confers 
protection against rhinoviral infection and assessing timing of intervention. It is also 
of interest to investigate any effects of IC on PAFR expression in secondary 
pneumococcal infections.  
7.2.3 Question 3: PAFR expression in COPD 
COPD is a chronic respiratory condition characterised by reduced lung function. 
COPD may be caused by chronic exposure to indoor pollution such as wood or 
biomass smoke or from chronic smoking61–63. Inflammation of the bronchi and 
damage of the small airways are common features of the condition. Additionally, 
there is evidence that COPD sufferers have an impaired immune response to 
bacterial and viral infections115,164.  
Rhinovirus infections are a common cause of COPD exacerbations and secondary 
bacterial infections are frequently reported. In a human model of experimental 
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rhinovirus infection it was observed that a significantly higher proportion of COPD 
patients developed secondary bacterial infections compared to smokers without 
COPD and healthy controls. The majority of these infections were caused by ChoP 
expressing bacteria such as S. pneumoniae and H. influenzae165. Since, as 
previously discussed, ChoP on the bacterial surface mimics PAF, binds PAFR and 
thus aids bacterial uptake into host cells, it was of interest to assess PAFR 
expression levels in the samples from this study. Additionally, based on the 
observation that COPD patients are more susceptible to bacterial infections it was 
hypothesised that they have higher baseline expression of PAFR compared to 
smokers and healthy controls. This hypothesis was also driven by the evidence that 
smoking per se causes increased PAFR expression in the bronchial epithelium123. 
Hence it was of interest to assess whether COPD has an additive effect on PAFR 
expression. Further, in a guinea pig model of COPD increased goblet cell 
metaplasia was seen in the epithelium which was attenuated by a PAFR 
antagonist116.  
Bronchial biopsies from healthy controls, smokers with normal lung function and 
smokers with COPD were examined at baseline and 7 days post-rhinoviral infection 
for PAFR mRNA expression. Smokers and smokers with COPD had higher baseline 
expression of PAFR mRNA compared to non-smokers but there was no significant 
difference between smokers and smokers with COPD. This suggests that the higher 
baseline PAFR expression in both smokers and smokers with COPD is driven by 
smoking rather than COPD per se. To date this is the first time that PAFR mRNA 
expression was analysed in smokers with COPD.  
Paired analyses of PAFR expression at baseline and 7 days after rhinovirus 
infection showed no differences in any of the groups. However, there was a trend 
towards higher expression in non-smokers after rhinovirus infection. This study was 
the first to look at the effect of a rhinovirus infection on PAFR expression in vivo. 
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There is in vitro evidence that PAFR expression and S. pneumoniae adherence is 
increased in rhinovirus infected nasal and pharyngeal cells30. This thesis presents 
the first evidence of a PAFR-dependent association between rhinovirus infection 
and S. pneumoniae adherence to bronchial and alveolar epithelial cells, and thus 
functional relevance for increased PAFR expression in the lungs after rhinovirus 
infection. However, the lack of statistical power in this study and the patchy nature 
of rhinovirus infection in vivo made it difficult to draw conclusions about whether 
rhinovirus infection increases PAFR expression in humans166.  
Comparing PAFR mRNA expression between groups 7 days after rhinovirus 
infection it was found that there were trends towards higher expression levels in 
COPD patients compared to healthy controls and smokers. A larger study with 
better statistical power may be able to resolve any differences between groups, if 
they exist, but it is difficult interpret these data.  
A limitation of studying PAFR mRNA expression in bronchial biopsies is a lack of 
information about which cells are expressing the mRNA, which is of functional 
relevance. Hence, it was of interest to assess PAFR protein expression in the 
biopsies using immunohistochemistry. As the samples were mined from a previous 
study, only a limited number of baseline samples where available for analysis. This 
made quantitative analysis difficult and so only qualitative observations were made 
about the samples. Goblet cell metaplasia, as observed in the previously mentioned 
guinea pig model of COPD, was seen in both smokers and smokers with COPD. 
Squamous metaplasia (SM), which is also a feature of COPD, was seen in both 
smokers and smokers with COPD. It was observed that areas of SM had lower 
PAFR staining compared to other types of epithelia. Whether this was a technical 
artefact or is due to a biological feature of the type of airway remodelling warrants 
further investigation. If areas of SM express lower amounts of PAFR it may be 
hypothesised that the type of airway remodelling is a protective mechanism. This 
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observation added to the difficulty of quantifying PAFR expression in these biopsies. 
A larger study with additional time points for both PAFR mRNA and protein 
expression seems a reasonable way forward for this work. 
Qualitative immunohistochemical analysis of the baseline bronchial biopsies of 
healthy controls, smokers and smokers with COPD showed that PAFR protein 
expression was restricted to the bronchial epithelium and the submucosal glands. 
Both these components of the small airways are in contact with inhaled air and thus 
with inhaled bacteria. The bronchial mucosal glands are responsible for mucus 
production in the airways. The patterns of PAFR expression seen suggest that the 
increased baseline PAFR mRNA expression measured may be mapped to areas 
that lie at the bronchial air-tissue interface. However, the functional relevance of this 
finding remains to be tested. Increased adherence of S. pneumoniae to bronchial 
epithelial cells exposed to cigarette smoke extract has been shown before but a 
similar effect in bronchial epithelial cells from COPD patients has not been shown to 
date123. 
7.3 Conclusions and a proposed mechanism for the role of PAFR in PM 
mediated vulnerability to pneumococcal pnuemonia 
7.3.1 Conclusions  
In summary, evidence for the following has been presented in this thesis: 
 A functional role of PAFR in WF-stimulated susceptibility to pneumococcal 
infection in lower airway epithelial cells and in nasal epithelial cells. 
Additionally, PAFR expression has been shown to be higher in mice 
exposed to WF, which are also more susceptible to pneumococcal infection, 
and in a welder. 
 A functional role for PAFR in rhinovirus- and WF+RV-16-stimulated 
secondary pneumococcal infection in lower airway epithelial cells. Iota 
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carrageenan has been shown to have anti-rhinoviral properties, with respect 
to secondary pneumococcal infection, in these cells but its effect on PAFR 
expression is yet unknown. 
 Higher baseline expression of PAFR in the bronchi of smokers with COPD, 
compared to non-smokers, and mapping of PAFR expression to cells at the 
bronchial air-tissue interface. The functional relevance of these findings is 
yet unknown. 
7.3.2 PAFR as an anti-infective target 
By putting this evidence in the context of the literature the author of this thesis would 
like to propose the following mechanism (figure 1) for a role of PAFR in airborne 
toxin-dependent vulnerability to pneumococcal infection. Airway epithelial cells are 
stimulated by inhaled toxins or inhaled toxins+rhinovirus. This leads to the 
upregulation of PAFR which is controlled by the transcription factor C/EBPδ10. The 
ChoP moiety of bacteria, such as S. pneumoniae, can then bind to the PAFR. The 
PAFR/pneumococcus complex is internalised in a clathrin dependent manner9. The 
complex stimulates the pro-inflammatory mediator NF-κB which in turn activates the 
inflammatory response. This includes the release of defensins and cytokines such 
as IL-8 and IL-1β18,69. The PAFR/pneumococcus complex is also recognised by β 
arrestin 1 which aids either its translocation across the epithelial barrier which may 
lead to invasive disease or its targeting to the cell surface which may lead to 
infection and colonisation9. It is proposed that PAFR may be a good anti-infective 
target in vulnerable populations such as welders and patients with COPD, which are 
chronically exposed to inhaled toxins.  
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Figure 1: Proposed mechanism for inhaled toxin- or RV+inhaled toxin-stimulated 
vulnerability of lower airway cells to pneumococcal infection, which is PAFR 
dependent and hence may be blocked by a PAFR antagonist. The ↑represents 
positive feedback. The ? represents as yet poorly understood elements of the 
mechanism which warrant further investigation. 
 
Thus the evidence presented in this thesis, from both in vitro and in vivo studies, 
suggests that the use of a PAFR antagonist may be a viable prevention and 
protection strategy in vulnerable populations. 
7.4 Future work 
The data presented in this thesis are the first which show biological plausibility of an 
association between exposure to WF and vulnerability to pneumococcal infection. 
The work is also a step towards understanding the molecular mechanisms involved 
in conferring this susceptibility. To date offering welders the pneumococcal vaccine 
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is not a regulatory requirement161. Hence, some of the wider implications of the data 
include: 
 A better understanding of exposure levels and better monitoring  
 Making it a requirement for employers to offer the pneumococcal vaccine to 
high risk welders such as those who smoke or are older 
 More research around PAFR as an anti-infective target and the development 
of PAFR antagonists 
Although the proposed mechanism outlined above focuses on a PAFR antagonist it 
would be of interest to investigate whether molecules downstream of PAFR in its 
signalling pathway may be potential drug targets. It is also of interest to better 
understand the role of PAFR in both colonisation and invasion of the host and the 
different mechanisms involved. This is because invasion is only seen in a proportion 
of welders who smoke in epidemiological studies and no invasive disease was seen 
in the mouse model of pneumococcal infection used for this thesis. Additionally, 
colonisation and not invasion is relevant to chronic respiratory conditions such as 
COPD and cystic fibrosis.  
Finally, although the focus of this thesis is PAFR, there are almost certainly other 
mechanisms and receptors involved19,24,25. It was shown that oxidative stress 
mechanisms are also involved in increasing susceptibility of lower airway cells to 
pneumococcal infection after exposure to WF. However what these mechanisms 
may be was not explored in depth. A high throughput approach to identifying genes 
involved in the response of lower airway epithelial cells to WF followed by a 
pneumococcal stimulus may provide useful information about the PAFR and other 
pathways involved.    
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